PedAM

Pediatric Disease Annotations & Medicines


	hepatitis

Disease ID	540
Disease	hepatitis
Definition	INFLAMMATION of the LIVER.
Synonym	hepatitides hepatitis (disorder) hepatitis [disease/finding] hepatitis nonspecific hepatitis nos hepatitis unspecified hepatitis unspecified (disorder) hepatitis unspecified nos hepatitis unspecified nos (disorder) hepatitis, nos hepatitis, unspecified inflammatory disease of liver inflammatory disease of liver (disorder) inflammatory disorder of liver inflammatory liver disease liver inflammation nonspecific hepatitis unspecified hepatitis
DOID	DOID:2237
UMLS	C0019158
MeSH	D006505
SNOMED-CT	SNOMEDCT_US_2016_09_01:128241005
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:492) C0023890 \| cirrhosis \| 358 C0019204 \| hepatocellular carcinoma \| 268 C0023895 \| liver disease \| 177 C0023890 \| liver cirrhosis \| 131 C0019163 \| hepatitis b \| 41 C0040034 \| thrombocytopenia \| 37 C0042769 \| viral infection \| 36 C0024299 \| lymphoma \| 35 C0011847 \| diabetes \| 35 C0011570 \| depression \| 34 C0008370 \| cholestasis \| 28 C0002871 \| anemia \| 27 C0019196 \| hepatitis c \| 27 C0023895 \| liver diseases \| 25 C0023903 \| liver cancer \| 24 C0010403 \| cryoglobulinemia \| 22 C0042384 \| vasculitis \| 21 C0022658 \| kidney disease \| 18 C0003864 \| arthritis \| 16 C0002878 \| hemolytic anemia \| 15 C0022658 \| renal disease \| 15 C0011849 \| diabetes mellitus \| 15 C0035078 \| renal failure \| 14 C0003873 \| rheumatoid arthritis \| 14 C0042769 \| virus infection \| 14 C0022661 \| chronic kidney disease \| 13 C0002880 \| autoimmune hemolytic anemia \| 13 C0021831 \| bowel disease \| 12 C0021390 \| inflammatory bowel disease \| 12 C0017658 \| glomerulonephritis \| 12 C0442874 \| neuropathy \| 12 C0024314 \| lymphoproliferative disorder \| 11 C0022658 \| nephropathy \| 11 C0033860 \| psoriasis \| 11 C0023418 \| leukemia \| 11 C0039730 \| thalassemia \| 11 C0019204 \| hepatoma \| 10 C0020538 \| hypertension \| 9 C0040147 \| thyroiditis \| 9 C0018378 \| guillain-barre syndrome \| 9 C0007570 \| celiac disease \| 9 C0206698 \| cholangiocarcinoma \| 9 C0039128 \| syphilis \| 8 C0041296 \| tuberculosis \| 8 C0014867 \| esophageal varices \| 8 C0008311 \| cholangitis \| 8 C0042345 \| varices \| 8 C0022660 \| acute renal failure \| 8 C0027947 \| neutropenia \| 8 C0022661 \| end-stage renal disease \| 8 C0023646 \| lichen planus \| 8 C0024314 \| lymphoproliferative disorders \| 8 C0019204 \| hepatocellular carcinomas \| 8 C0948265 \| metabolic syndrome \| 8 C0042769 \| viral infections \| 8 C0023434 \| chronic lymphocytic leukemia \| 7 C0032285 \| pneumonia \| 7 C0026769 \| multiple sclerosis \| 7 C0019829 \| hodgkin's lymphoma \| 7 C0031036 \| polyarteritis nodosa \| 7 C0034362 \| q fever \| 7 C0006142 \| breast cancer \| 7 C0241910 \| autoimmune hepatitis \| 7 C0036202 \| sarcoidosis \| 7 C0028754 \| obesity \| 7 C0023448 \| lymphocytic leukemia \| 7 C0085253 \| adult-onset still's disease \| 6 C0008049 \| varicella \| 6 C0002871 \| anaemia \| 6 C0023890 \| hepatic cirrhosis \| 6 C0040053 \| thrombosis \| 6 C0019069 \| haemophilia \| 6 C0019151 \| hepatic encephalopathy \| 6 C0001339 \| acute pancreatitis \| 6 C0024305 \| non-hodgkin's lymphoma \| 6 C0021053 \| immune disease \| 6 C0008325 \| cholecystitis \| 6 C0345905 \| intrahepatic cholangiocarcinoma \| 6 C0034902 \| pure red cell aplasia \| 5 C0019069 \| hemophilia \| 5 C0030305 \| pancreatitis \| 5 C0008312 \| biliary cirrhosis \| 5 C0018213 \| graves' disease \| 5 C0008312 \| primary biliary cirrhosis \| 5 C0037317 \| sleep disturbance \| 5 C0022354 \| cholestatic jaundice \| 5 C0018801 \| heart failure \| 5 C0025289 \| meningitis \| 5 C0281963 \| red cell aplasia \| 5 C0034150 \| purpura \| 5 C0001973 \| alcoholism \| 5 C0079731 \| b-cell lymphoma \| 5 C0026764 \| myeloma \| 5 C0079744 \| diffuse large b-cell lymphoma \| 5 C0267841 \| acalculous cholecystitis \| 5 C0017665 \| membranous nephropathy \| 5 C0015230 \| rash \| 4 C0026764 \| multiple myeloma \| 4 C0005283 \| beta thalassemia \| 4 C0029132 \| optic neuropathy \| 4 C0011860 \| type 2 diabetes \| 4 C0041466 \| typhoid fever \| 4 C0282193 \| iron overload \| 4 C0008372 \| intrahepatic cholestasis \| 4 C0024299 \| lymphomas \| 4 C0010346 \| crohn's disease \| 4 C0033687 \| proteinuria \| 4 C0920350 \| autoimmune thyroiditis \| 4 C0018916 \| hemangioma \| 4 C0085655 \| polymyositis \| 4 C0019212 \| hepatorenal syndrome \| 4 C0035435 \| rheumatic disease \| 4 C0002874 \| aplastic anemia \| 4 C0085293 \| hepatitis e \| 4 C0025309 \| meningoencephalitis \| 4 C0026848 \| myopathy \| 4 C0017661 \| iga nephropathy \| 4 C0014867 \| oesophageal varices \| 4 C0011860 \| type 2 diabetes mellitus \| 4 C0004153 \| atherosclerosis \| 4 C0018799 \| heart disease \| 4 C0036323 \| schistosomiasis \| 4 C0032285 \| pneumonitis \| 4 C0037317 \| sleep disturbances \| 4 C0020532 \| hypersplenism \| 3 C0006309 \| brucellosis \| 3 C0015624 \| fanconi syndrome \| 3 C0409974 \| lupus erythematosus \| 3 C0021359 \| infertile \| 3 C0030312 \| pancytopenia \| 3 C0040128 \| thyroid disease \| 3 C0024115 \| pulmonary disease \| 3 C0024305 \| non-hodgkin lymphoma \| 3 C0023343 \| leprosy \| 3 C0040128 \| thyroid disorders \| 3 C0022661 \| chronic renal failure \| 3 C0023903 \| liver tumor \| 3 C0026946 \| fungal infection \| 3 C0027726 \| nephrotic syndrome \| 3 C0085436 \| cryptococcal meningitis \| 3 C0002726 \| amyloidosis \| 3 C0029134 \| optic neuritis \| 3 C0035435 \| rheumatic diseases \| 3 C0025202 \| melanoma \| 3 C0020541 \| portal hypertension \| 3 C0376545 \| hematological malignancies \| 3 C0009319 \| colitis \| 3 C0002878 \| haemolytic anaemia \| 3 C0011226 \| hepatitis d \| 3 C0272286 \| immune thrombocytopenia \| 3 C0026975 \| myelitis \| 3 C1565489 \| renal insufficiency \| 3 C0031154 \| peritonitis \| 3 C0004623 \| bacterial infection \| 3 C0010068 \| coronary artery disease \| 3 C0016053 \| fibromyalgia \| 3 C0017662 \| membranoproliferative glomerulonephritis \| 3 C0019829 \| hodgkin lymphoma \| 3 C0003467 \| anxiety \| 3 C0235618 \| proliferative glomerulonephritis \| 3 C0035309 \| retinopathy \| 3 C0041466 \| typhoid \| 3 C0027813 \| neuritis \| 3 C1561644 \| chronic kidney disease (ckd) \| 2 C0037274 \| skin disorder \| 2 C0023895 \| liver disorders \| 2 C0085253 \| adult-onset still disease \| 2 C0023449 \| acute lymphoblastic leukemia \| 2 C0007113 \| rectal cancer \| 2 C0039446 \| telangiectasia \| 2 C0085253 \| adult onset still's disease \| 2 C0019163 \| viral hepatitis b \| 2 C0011644 \| scleroderma \| 2 C0009324 \| ulcerative colitis \| 2 C0042870 \| vitamin d deficiency \| 2 C0023895 \| liver disorder \| 2 C0001125 \| lactic acidosis \| 2 C0000889 \| acanthosis nigricans \| 2 C0020456 \| hyperglycemia \| 2 C0023448 \| lymphoblastic leukemia \| 2 C0011854 \| type 1 diabetes \| 2 C0010403 \| cryoglobulinaemia \| 2 C0376175 \| bell's palsy \| 2 C0009782 \| connective tissue disease \| 2 C0040188 \| tic disorders \| 2 C0042870 \| vitamin d defic \| 2 C0021364 \| male infertility \| 2 C0040100 \| thymoma \| 2 C0026848 \| muscular disorders \| 2 C0023364 \| leptospirosis \| 2 C0025637 \| methemoglobinemia \| 2 C0020676 \| hypothyroidism \| 2 C0037274 \| skin disease \| 2 C0019204 \| hepatocarcinoma \| 2 C0037274 \| skin diseases \| 2 C0020455 \| hypergammaglobulinemia \| 2 C0036421 \| systemic sclerosis \| 2 C0024141 \| systemic lupus erythematosus \| 2 C0023470 \| myeloid leukemia \| 2 C0008313 \| sclerosing cholangitis \| 2 C0011854 \| type i diabetes \| 2 C0041696 \| major depression \| 2 C0001175 \| acquired immunodeficiency syndrome \| 2 C0042721 \| viral hepatitis \| 2 C0085273 \| parvovirus b19 infection \| 2 C0023895 \| hepatic disease \| 2 C0014070 \| encephalomyelitis \| 2 C0031117 \| peripheral neuropathy \| 2 C0026896 \| myasthenia gravis \| 2 C0235974 \| pancreatic cancer \| 2 C0004096 \| asthma \| 2 C0030312 \| bone marrow failure \| 2 C0009241 \| cognitive disorders \| 2 C0566602 \| primary sclerosing cholangitis \| 2 C0036341 \| schizophrenia \| 2 C0032302 \| mycoplasma pneumonia \| 2 C0242647 \| mucosa-associated lymphoid tissue lymphoma \| 2 C0019360 \| zoster \| 2 C0021359 \| infertility \| 2 C0001824 \| agranulocytosis \| 2 C0014038 \| encephalitis \| 2 C0014059 \| acute disseminated encephalomyelitis \| 2 C0017665 \| membranous glomerulonephritis \| 2 C0027868 \| neuromuscular disorders \| 2 C0011633 \| dermatomyositis \| 2 C0002892 \| pernicious anemia \| 2 C0014868 \| esophagitis \| 2 C0041327 \| pulmonary tuberculosis \| 2 C0011991 \| diarrhea \| 2 C0024291 \| hemophagocytic lymphohistiocytosis \| 2 C0037274 \| skin disorders \| 2 C0023467 \| acute myeloid leukemia \| 2 C0024291 \| hemophagocytic syndrome \| 2 C0036285 \| scarlet fever \| 2 C0032285 \| pneumoniae \| 2 C0152025 \| polyneuropathy \| 1 C0001175 \| acquired immune deficiency \| 1 C0022350 \| dubin-johnson syndrome \| 1 C0001418 \| adenocarcinoma \| 1 C0032827 \| k deficiency \| 1 C0009402 \| colorectal cancer \| 1 C0043117 \| immune thrombocytopenic purpura \| 1 C0017168 \| gastroesophageal reflux disease \| 1 C0014179 \| uterine infection \| 1 C0027868 \| neuromuscular disease \| 1 C0018799 \| cardiac disorders \| 1 C0030528 \| paratyphoid fever \| 1 C1112746 \| hepatic lymphoma \| 1 C0032587 \| polyradiculoneuropathy \| 1 C0020598 \| hypoglycaemia \| 1 C0024301 \| follicular lymphoma \| 1 C0019202 \| wilson's disease \| 1 C0026934 \| mycoplasma \| 1 C0155773 \| portal vein thrombosis \| 1 C0677607 \| hashimoto thyroiditis \| 1 C0029456 \| osteoporosis \| 1 C0043092 \| wegener's granulomatosis \| 1 C0243010 \| viral encephalitis \| 1 C0036420 \| localized scleroderma \| 1 C0018021 \| goiter \| 1 C0026986 \| myelodysplastic syndrome \| 1 C0013502 \| echinococcosis \| 1 C0029106 \| opisthorchiasis \| 1 C0018991 \| hemiplegia \| 1 C0162429 \| malnutrition \| 1 C0836924 \| thrombocytosis \| 1 C0037274 \| dermatologic disease \| 1 C0020502 \| hyperparathyroidism \| 1 C0023470 \| myeloid leukaemia \| 1 C0018023 \| nodular goiter \| 1 C0014060 \| encephalitis c \| 1 C0011881 \| diabetic nephropathy \| 1 C0026848 \| muscular diseases \| 1 C0024530 \| malaria \| 1 C0032305 \| pneumocystis \| 1 C0008370 \| bile duct obstruction \| 1 C1704214 \| xanthogranuloma \| 1 C0035078 \| kidney failure \| 1 C0679466 \| cognitive deficits \| 1 C0039445 \| hereditary hemorrhagic telangiectasia \| 1 C0003469 \| anxiety disorder \| 1 C0040149 \| subacute thyroiditis \| 1 C0242363 \| islet cell tumor \| 1 C0494491 \| mononeuropathy \| 1 C0027051 \| myocardial infarct \| 1 C0037061 \| siderosis \| 1 C0026848 \| myopathies \| 1 C0701818 \| choledocholithiasis \| 1 C0024117 \| chronic obstructive pulmonary disease \| 1 C0751711 \| anterior ischemic optic neuropathy \| 1 C0036262 \| scabies \| 1 C0001621 \| adrenal disease \| 1 C0024198 \| lyme disease \| 1 C0040156 \| thyrotoxicosis \| 1 C0002880 \| autoimmune haemolytic anaemia \| 1 C0002895 \| sickle cell anemia \| 1 C0019196 \| hepatitis c infection \| 1 C0023895 \| hepatopathy \| 1 C0021390 \| inflammatory bowel diseases \| 1 C0003872 \| psoriatic arthritis \| 1 C0042769 \| viral disease \| 1 C0162429 \| poor nutrition \| 1 C0023487 \| acute promyelocytic leukemia \| 1 C0037274 \| dermatosis \| 1 C0242342 \| sheehan's syndrome \| 1 C0017168 \| esophageal reflux \| 1 C0014130 \| endocrinopathy \| 1 C0861876 \| recurrent hepatocellular carcinoma \| 1 C0035333 \| retinitis \| 1 C0011991 \| diarrhoea \| 1 C0162566 \| porphyria cutanea tarda \| 1 C0001206 \| acromegaly \| 1 C0036337 \| schizoaffective disorder \| 1 C0027059 \| myocarditis \| 1 C0152445 \| gallbladder hydrops \| 1 C0034155 \| thrombotic thrombocytopenic purpura \| 1 C0042164 \| uveitis \| 1 C0278883 \| metastatic melanoma \| 1 C0008049 \| varicella infection \| 1 C0238246 \| liver hemangioma \| 1 C0085315 \| cerebral toxoplasmosis \| 1 C0238124 \| necrotizing fasciitis \| 1 C0027721 \| minimal change nephropathy \| 1 C0042373 \| vascular disorders \| 1 C0027051 \| myocardial infarction \| 1 C0042900 \| vitiligo \| 1 C0007570 \| coeliac disease \| 1 C0030807 \| pemphigus \| 1 C0085434 \| bacillary angiomatosis \| 1 C0859939 \| classic polyarteritis nodosa \| 1 C0020542 \| pulmonary hypertension \| 1 C0270612 \| leukoencephalopathy \| 1 C0010631 \| cystadenocarcinoma \| 1 C0221406 \| cushing's disease \| 1 C0040127 \| thyroid storm \| 1 C0178238 \| intestinal infection \| 1 C0019360 \| herpes zoster \| 1 C0018920 \| cavernous hemangioma \| 1 C1334028 \| hilar cholangiocarcinoma \| 1 C0403529 \| pulmonary-renal syndrome \| 1 C0012739 \| disseminated intravascular coagulation \| 1 C0270549 \| generalized anxiety disorder \| 1 C0341052 \| chronic sialadenitis \| 1 C0494165 \| liver metastases \| 1 C0221757 \| alpha 1-antitrypsin deficiency \| 1 C0085404 \| poems syndrome \| 1 C0079731 \| b-cell non-hodgkin lymphoma \| 1 C0022104 \| irritable bowel syndrome \| 1 C0085273 \| erythema infectiosum \| 1 C0026272 \| mixed connective tissue disease \| 1 C0023434 \| small lymphocytic lymphoma \| 1 C0271650 \| glucose intolerance \| 1 C0027121 \| myositis \| 1 C0023281 \| leishmaniasis \| 1 C0861772 \| metastatic rectal cancer \| 1 C0017636 \| glioblastoma \| 1 C2700641 \| lymphoplasmacytic lymphoma \| 1 C0042109 \| urticaria \| 1 C0242350 \| erectile dysfunction \| 1 C0025322 \| early menopause \| 1 C0017160 \| gastroenteritis \| 1 C0021053 \| immune disorder \| 1 C0032453 \| relapsing polychondritis \| 1 C0028242 \| nocardiosis \| 1 C0019100 \| dengue haemorrhagic fever \| 1 C0025007 \| measles \| 1 C0023290 \| visceral leishmaniasis \| 1 C0022658 \| renal diseases \| 1 C0022658 \| kidney diseases \| 1 C0015645 \| fasciitis \| 1 C0023891 \| alcoholic cirrhosis \| 1 C0040558 \| toxoplasmosis \| 1 C0314719 \| dry eye \| 1 C0017168 \| oesophageal reflux \| 1 C0001430 \| adenoma \| 1 C0034072 \| cardiopulmonary disease \| 1 C0003509 \| aortitis \| 1 C1527336 \| sjogren's syndrome \| 1 C0003873 \| rheumatoid disease \| 1 C0013418 \| abnormal labor \| 1 C0032298 \| lipoid pneumonia \| 1 C0007137 \| squamous cell carcinoma \| 1 C0677607 \| hashimoto's thyroiditis \| 1 C0022104 \| irritable bowel \| 1 C0040128 \| thyroid diseases \| 1 C0007642 \| cellulitis \| 1 C0600260 \| obstructive pulmonary disease \| 1 C0034212 \| pyoderma \| 1 C0020619 \| hypogonadism \| 1 C0024115 \| pulmonary diseases \| 1 C0018203 \| chronic granulomatous disease \| 1 C0024117 \| chronic obstructive pulmonary disease (copd) \| 1 C0023787 \| lipodystrophy \| 1 C0037198 \| sinus thrombosis \| 1 C0027697 \| nephritis \| 1 C0042373 \| vascular disorder \| 1 C0011334 \| caries \| 1 C0019163 \| hepatitis b infection \| 1 C0023434 \| lymphocytic lymphoma \| 1 C0004712 \| balo's concentric sclerosis \| 1 C0023487 \| promyelocytic leukemia \| 1 C0023903 \| hepatic tumor \| 1 C1262481 \| eosinophilic gastroenteritis \| 1 C0020479 \| apolipoprotein e deficiency \| 1 C0017920 \| glucose-6-phosphate dehydrogenase deficiency \| 1 C0023470 \| myelocytic leukemia \| 1 C0149985 \| secondary syphilis \| 1 C0023492 \| t-cell leukemia \| 1 C0162839 \| porokeratosis \| 1 C0011854 \| type i diabetes mellitus \| 1 C1302401 \| colorectal adenoma \| 1 C0033953 \| sexual dysfunction \| 1 C0026986 \| myelodysplastic syndromes \| 1 C0041696 \| major depressive disorder \| 1 C0019348 \| herpes simplex \| 1 C1136085 \| monoclonal gammopathy \| 1 C0025293 \| listeria monocytogenes meningitis \| 1 C0264716 \| chronic heart failure \| 1 C0023895 \| hepatic disorders \| 1 C0751878 \| central nervous system vasculitis \| 1 C0032708 \| porphyria \| 1 C0036203 \| cutaneous sarcoid \| 1 C0242647 \| malt lymphoma \| 1 C0242647 \| mucosa-associated lymphoid tissue \| 1 C0011854 \| type 1 diabetes mellitus \| 1 C0021400 \| influenza \| 1 C0079731 \| b cell lymphoma \| 1 C0159069 \| impaired glucose tolerance \| 1 C0017168 \| gastroesophageal reflux \| 1 C0023493 \| adult t-cell leukemia-lymphoma \| 1 C0020550 \| hyperthyroidism \| 1 C0152021 \| congenital heart disease \| 1 C0023473 \| chronic myeloid leukaemia \| 1 C0019087 \| hemorrhagic diathesis \| 1 C0020598 \| hypoglycemia \| 1 C0004623 \| bacterial infections \| 1 C0007131 \| nsclc \| 1 C0030528 \| paratyphoid \| 1 C0009447 \| common variable immunodeficiency \| 1 C0027873 \| neuromyelitis optica \| 1 C0001175 \| acquired immune deficiency syndrome \| 1 C0012739 \| disseminated intravascular coagulation (dic) \| 1 C0079731 \| b-cell non-hodgkin's lymphoma \| 1 C0015930 \| fetal distress \| 1 C0022661 \| end stage renal disease \| 1 C0494165 \| hepatic metastasis \| 1 C0021053 \| immune disorders \| 1 C0004030 \| aspergillosis \| 1 C0017168 \| esophageal reflux disease \| 1 C0024623 \| gastric cancer \| 1 C0268397 \| cutaneous amyloidosis \| 1 C0019147 \| hepatic coma \| 1 C0949690 \| spondyloarthritis \| 1 C0003125 \| anorexia nervosa \| 1 C0023434 \| b cell chronic lymphocytic leukemia \| 1 C0271650 \| prediabetes \| 1 C0034152 \| henoch-schoenlein purpura \| 1 C0334533 \| arteriovenous hemangioma \| 1 C1621958 \| glioblastoma multiforme \| 1 C0079731 \| b-cell lymphomas \| 1 C0376545 \| hematological malignancy \| 1 C0006271 \| bronchiolitis \| 1 C0019163 \| serum hepatitis \| 1 C0151295 \| mononeuritis multiplex \| 1 C0085652 \| pyoderma gangrenosum \| 1 C0677607 \| lymphocytic thyroiditis \| 1 C0024312 \| lymphopenia \| 1 C0006625 \| cachectic \| 1 C0270922 \| demyelinating neuropathy \| 1 C0023903 \| hepatic cancer \| 1 C0086543 \| cataract \| 1 C0019187 \| alcoholic hepatitis \| 1 C0023493 \| adult t-cell leukemia \| 1 C0242770 \| bronchiolitis obliterans organizing pneumonia \| 1 C0006017 \| pertussis \| 1 C0036203 \| cutaneous sarcoidosis \| 1 C0162529 \| ischemic colitis \| 1 C1333387 \| endocrine syndrome \| 1 C0026946 \| fungal infections \| 1 C0010414 \| cryptococcosis \| 1 C0004626 \| bacterial pneumonia \| 1 C0034065 \| pulmonary embolism \| 1 C0221032 \| generalized lipodystrophy \| 1 C1510472 \| drug addiction \| 1 C0004352 \| autism \| 1 C0014544 \| epilepsy \| 1 C0497327 \| dementia \| 1 C0151313 \| sensory neuropathy \| 1 C0027868 \| neuromuscular diseases \| 1 C1337035 \| xanthogranulomatous cholecystitis \| 1 C1619734 \| pulmonary arterial hypertension \| 1 C0001175 \| acquired immunodeficiency syndrome (aids) \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:19) INS \| 3630 \| CTD_human KEAP1 \| 9817 \| CTD_human IFNG \| 3458 \| CTD_human HMOX1 \| 3162 \| CTD_human PARP1 \| 142 \| CTD_human ALB \| 213 \| CTD_human CAT \| 847 \| CTD_human ATP7B \| 540 \| CTD_human GNMT \| 27232 \| CTD_human FASLG \| 356 \| CTD_human SPARC \| 6678 \| CTD_human TF \| 7018 \| CTD_human GZMB \| 3002 \| CTD_human CASC15 \| 401237 \| GWASCAT ENPP2 \| 5168 \| CTD_human GABRG3 \| 2567 \| GWASCAT F2R \| 2149 \| CTD_human SYT16 \| 83851 \| GWASCAT NAV2 \| 89797 \| GWASCAT
Inferring Gene	Entrez_id \| Symbol \| Resource(Total Genes:9) 1493 \| CTLA4 \| infer 1571 \| CYP2E1 \| infer 3123 \| HLA-DRB1 \| infer 3586 \| IL10 \| infer 3552 \| IL1A \| infer 3553 \| IL1B \| infer 3557 \| IL1RN \| infer 3569 \| IL6 \| infer 9 \| NAT1 \| infer
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:725) 6376 \| CX3CL1 \| DISEASES 920 \| CD4 \| DISEASES 84957 \| RELT \| DISEASES 84699 \| CREB3L3 \| DISEASES 9716 \| AQR \| DISEASES 3385 \| ICAM3 \| DISEASES 83992 \| CTTNBP2 \| DISEASES 634 \| CEACAM1 \| DISEASES 7132 \| TNFRSF1A \| DISEASES 9950 \| GOLGA5 \| DISEASES 3566 \| IL4R \| DISEASES 9817 \| KEAP1 \| DISEASES 30009 \| TBX21 \| DISEASES 10777 \| ARPP21 \| DISEASES 7066 \| THPO \| DISEASES 350 \| APOH \| DISEASES 124 \| ADH1A \| DISEASES 25984 \| KRT23 \| DISEASES 23411 \| SIRT1 \| DISEASES 266 \| AMELY \| DISEASES 4282 \| MIF \| DISEASES 11274 \| USP18 \| DISEASES 5594 \| MAPK1 \| DISEASES 3162 \| HMOX1 \| DISEASES 80339 \| PNPLA3 \| DISEASES 3002 \| GZMB \| DISEASES 6554 \| SLC10A1 \| DISEASES 4792 \| NFKBIA \| DISEASES 3929 \| LBP \| DISEASES 51311 \| TLR8 \| DISEASES 2158 \| F9 \| DISEASES 7076 \| TIMP1 \| DISEASES 479 \| ATP12A \| DISEASES 4313 \| MMP2 \| DISEASES 2137 \| EXTL3 \| DISEASES 7038 \| TG \| DISEASES 1666 \| DECR1 \| DISEASES 2936 \| GSR \| DISEASES 8797 \| TNFRSF10A \| DISEASES 54793 \| KCTD9 \| DISEASES 56729 \| RETN \| DISEASES 2091 \| FBL \| DISEASES 7040 \| TGFB1 \| DISEASES 973 \| CD79A \| DISEASES 1048 \| CEACAM5 \| DISEASES 57817 \| HAMP \| DISEASES 5444 \| PON1 \| DISEASES 3082 \| HGF \| DISEASES 10135 \| NAMPT \| DISEASES 858 \| CAV2 \| DISEASES 7036 \| TFR2 \| DISEASES 5054 \| SERPINE1 \| DISEASES 6348 \| CCL3 \| DISEASES 4353 \| MPO \| DISEASES 1440 \| CSF3 \| DISEASES 1362 \| CPD \| DISEASES 6347 \| CCL2 \| DISEASES 7448 \| VTN \| DISEASES 230 \| ALDOC \| DISEASES 952 \| CD38 \| DISEASES 51056 \| LAP3 \| DISEASES 3558 \| IL2 \| DISEASES 3732 \| CD82 \| DISEASES 595 \| CCND1 \| DISEASES 3587 \| IL10RA \| DISEASES 969 \| CD69 \| DISEASES 4055 \| LTBR \| DISEASES 3458 \| IFNG \| DISEASES 2597 \| GAPDH \| DISEASES 7167 \| TPI1 \| DISEASES 57379 \| AICDA \| DISEASES 3820 \| KLRB1 \| DISEASES 135152 \| B3GAT2 \| DISEASES 9841 \| ZBTB24 \| DISEASES 6908 \| TBP \| DISEASES 3565 \| IL4 \| DISEASES 3567 \| IL5 \| DISEASES 5610 \| EIF2AK2 \| DISEASES 338 \| APOB \| DISEASES 3554 \| IL1R1 \| DISEASES 5657 \| PRTN3 \| DISEASES 6402 \| SELL \| DISEASES 1509 \| CTSD \| DISEASES 335 \| APOA1 \| DISEASES 7276 \| TTR \| DISEASES 9615 \| GDA \| DISEASES 4360 \| MRC1 \| DISEASES 51569 \| UFM1 \| DISEASES 847 \| CAT \| DISEASES 8743 \| TNFSF10 \| DISEASES 92014 \| SLC25A51 \| DISEASES 28981 \| IFT81 \| DISEASES 540 \| ATP7B \| DISEASES 6626 \| SNRPA \| DISEASES 10384 \| BTN3A3 \| DISEASES 1026 \| CDKN1A \| DISEASES 2806 \| GOT2 \| DISEASES 3659 \| IRF1 \| DISEASES 30833 \| NT5C \| DISEASES 79143 \| MBOAT7 \| DISEASES 718 \| C3 \| DISEASES 10045 \| SH2D3A \| DISEASES 7389 \| UROD \| DISEASES 1236 \| CCR7 \| DISEASES 7355 \| SLC35A2 \| DISEASES 5199 \| CFP \| DISEASES 2671 \| GFER \| DISEASES 10875 \| FGL2 \| DISEASES 2678 \| GGT1 \| DISEASES 2952 \| GSTT1 \| DISEASES 968 \| CD68 \| DISEASES 6351 \| CCL4 \| DISEASES 3630 \| INS \| DISEASES 5894 \| RAF1 \| DISEASES 348 \| APOE \| DISEASES 55821 \| ALLC \| DISEASES 684 \| BST2 \| DISEASES 2056 \| EPO \| DISEASES 1571 \| CYP2E1 \| DISEASES 445 \| ASS1 \| DISEASES 10343 \| PKDREJ \| DISEASES 9104 \| RGN \| DISEASES 2161 \| F12 \| DISEASES 2538 \| G6PC \| DISEASES 8431 \| NR0B2 \| DISEASES 3958 \| LGALS3 \| DISEASES 5989 \| RFX1 \| DISEASES 6737 \| TRIM21 \| DISEASES 23225 \| NUP210 \| DISEASES 5791 \| PTPRE \| DISEASES 1401 \| CRP \| DISEASES 325 \| APCS \| DISEASES 1116 \| CHI3L1 \| DISEASES 3845 \| KRAS \| DISEASES 1965 \| EIF2S1 \| DISEASES 9695 \| EDEM1 \| DISEASES 10752 \| CHL1 \| DISEASES 23175 \| LPIN1 \| DISEASES 10468 \| FST \| DISEASES 10599 \| SLCO1B1 \| DISEASES 6927 \| HNF1A \| DISEASES 8638 \| OASL \| DISEASES 4907 \| NT5E \| DISEASES 10024 \| TROAP \| DISEASES 3569 \| IL6 \| DISEASES 3557 \| IL1RN \| DISEASES 26525 \| IL36RN \| DISEASES 9394 \| HS6ST1 \| DISEASES 2995 \| GYPC \| DISEASES 570 \| BAAT \| DISEASES 5168 \| ENPP2 \| DISEASES 3442 \| IFNA5 \| DISEASES 8737 \| RIPK1 \| DISEASES 7097 \| TLR2 \| DISEASES 10068 \| IL18BP \| DISEASES 1559 \| CYP2C9 \| DISEASES 6741 \| SSB \| DISEASES 9360 \| PPIG \| DISEASES 30061 \| SLC40A1 \| DISEASES 10063 \| COX17 \| DISEASES 4659 \| PPP1R12A \| DISEASES 4069 \| LYZ \| DISEASES 7450 \| VWF \| DISEASES 949 \| SCARB1 \| DISEASES 217 \| ALDH2 \| DISEASES 999 \| CDH1 \| DISEASES 9172 \| MYOM2 \| DISEASES 4591 \| TRIM37 \| DISEASES 495 \| ATP4A \| DISEASES 5465 \| PPARA \| DISEASES 7077 \| TIMP2 \| DISEASES 3959 \| LGALS3BP \| DISEASES 671 \| BPI \| DISEASES 25939 \| SAMHD1 \| DISEASES 5595 \| MAPK3 \| DISEASES 23523 \| CABIN1 \| DISEASES 4924 \| NUCB1 \| DISEASES 3552 \| IL1A \| DISEASES 3553 \| IL1B \| DISEASES 645 \| BLVRB \| DISEASES 9466 \| IL27RA \| DISEASES 55717 \| WDR11 \| DISEASES 1991 \| ELANE \| DISEASES 64135 \| IFIH1 \| DISEASES 975 \| CD81 \| DISEASES 9410 \| SNRNP40 \| DISEASES 4072 \| EPCAM \| DISEASES 8647 \| ABCB11 \| DISEASES 3574 \| IL7 \| DISEASES 943 \| TNFRSF8 \| DISEASES 3931 \| LCAT \| DISEASES 3299 \| HSF4 \| DISEASES 1716 \| DGUOK \| DISEASES 941 \| CD80 \| DISEASES 590 \| BCHE \| DISEASES 59067 \| IL21 \| DISEASES 2247 \| FGF2 \| DISEASES 1356 \| CP \| DISEASES 6774 \| STAT3 \| DISEASES 80725 \| SRCIN1 \| DISEASES 5443 \| POMC \| DISEASES 7297 \| TYK2 \| DISEASES 3383 \| ICAM1 \| DISEASES 54464 \| XRN1 \| DISEASES 64083 \| GOLPH3 \| DISEASES 1950 \| EGF \| DISEASES 1390 \| CREM \| DISEASES 320 \| APBA1 \| DISEASES 127 \| ADH4 \| DISEASES 4547 \| MTTP \| DISEASES 644 \| BLVRA \| DISEASES 51083 \| GAL \| DISEASES 5244 \| ABCB4 \| DISEASES 63898 \| SH2D4A \| DISEASES 5286 \| PIK3C2A \| DISEASES 3263 \| HPX \| DISEASES 56938 \| ARNTL2 \| DISEASES 939 \| CD27 \| DISEASES 6652 \| SORD \| DISEASES 1583 \| CYP11A1 \| DISEASES 3687 \| ITGAX \| DISEASES 432 \| ASGR1 \| DISEASES 7157 \| TP53 \| DISEASES 3454 \| IFNAR1 \| DISEASES 207 \| AKT1 \| DISEASES 5298 \| PI4KB \| DISEASES 3756 \| KCNH1 \| DISEASES 2052 \| EPHX1 \| DISEASES 5972 \| REN \| DISEASES 805 \| CALM2 \| DISEASES 165530 \| CLEC4F \| DISEASES 167410 \| LIX1 \| DISEASES 3950 \| LECT2 \| DISEASES 134864 \| TAAR1 \| DISEASES 1956 \| EGFR \| DISEASES 8795 \| TNFRSF10B \| DISEASES 3439 \| IFNA1 \| DISEASES 3934 \| LCN2 \| DISEASES 4851 \| NOTCH1 \| DISEASES 1737 \| DLAT \| DISEASES 3606 \| IL18 \| DISEASES 5805 \| PTS \| DISEASES 5741 \| PTH \| DISEASES 925 \| CD8A \| DISEASES 5205 \| ATP8B1 \| DISEASES 6317 \| SERPINB3 \| DISEASES 136991 \| ASZ1 \| DISEASES 8714 \| ABCC3 \| DISEASES 231 \| AKR1B1 \| DISEASES 9601 \| PDIA4 \| DISEASES 10 \| NAT2 \| DISEASES 27163 \| NAAA \| DISEASES 10563 \| CXCL13 \| DISEASES 7547 \| ZIC3 \| DISEASES 6750 \| SST \| DISEASES 5468 \| PPARG \| DISEASES 3815 \| KIT \| DISEASES 6296 \| ACSM3 \| DISEASES 29881 \| NPC1L1 \| DISEASES 11309 \| SLCO2B1 \| DISEASES 3588 \| IL10RB \| DISEASES 539 \| ATP5O \| DISEASES 64843 \| ISL2 \| DISEASES 1636 \| ACE \| DISEASES 808 \| CALM3 \| DISEASES 326 \| AIRE \| DISEASES 10841 \| FTCD \| DISEASES 2220 \| FCN2 \| DISEASES 9437 \| NCR1 \| DISEASES 729230 \| CCR2 \| DISEASES 1234 \| CCR5 \| DISEASES 3046 \| HBE1 \| DISEASES 114757 \| CYGB \| DISEASES 6352 \| CCL5 \| DISEASES 3856 \| KRT8 \| DISEASES 3889 \| KRT83 \| DISEASES 7412 \| VCAM1 \| DISEASES 2215 \| FCGR3B \| DISEASES 5966 \| REL \| DISEASES 27306 \| HPGDS \| DISEASES 10461 \| MERTK \| DISEASES 248 \| ALPI \| DISEASES 9076 \| CLDN1 \| DISEASES 2168 \| FABP1 \| DISEASES 213 \| ALB \| DISEASES 7047 \| TGM4 \| DISEASES 1230 \| CCR1 \| DISEASES 128 \| ADH5 \| DISEASES 327 \| APEH \| DISEASES 308 \| ANXA5 \| DISEASES 3600 \| IL15 \| DISEASES 6690 \| SPINK1 \| DISEASES 9607 \| CARTPT \| DISEASES 7098 \| TLR3 \| DISEASES 27242 \| TNFRSF21 \| DISEASES 1437 \| CSF2 \| DISEASES 168667 \| BMPER \| DISEASES 3429 \| IFI27 \| DISEASES 3990 \| LIPC \| DISEASES 7184 \| HSP90B1 \| DISEASES 4314 \| MMP3 \| DISEASES 5479 \| PPIB \| DISEASES 6778 \| STAT6 \| DISEASES 5245 \| PHB \| DISEASES 1548 \| CYP2A6 \| DISEASES 10653 \| SPINT2 \| DISEASES 124935 \| SLC43A2 \| DISEASES 133418 \| EMB \| DISEASES 598 \| BCL2L1 \| DISEASES 3479 \| IGF1 \| DISEASES 3308 \| HSPA4 \| DISEASES 10972 \| TMED10 \| DISEASES 54578 \| UGT1A6 \| DISEASES 23179 \| RGL1 \| DISEASES 29 \| ABR \| DISEASES 1493 \| CTLA4 \| DISEASES 5068 \| REG3A \| DISEASES 10663 \| CXCR6 \| DISEASES 171558 \| PTCRA \| DISEASES 375611 \| SLC26A5 \| DISEASES 54658 \| UGT1A1 \| DISEASES 3596 \| IL13 \| DISEASES 84342 \| COG8 \| DISEASES 3627 \| CXCL10 \| DISEASES 7399 \| USH2A \| DISEASES 6579 \| SLCO1A2 \| DISEASES 3575 \| IL7R \| DISEASES 7369 \| UMOD \| DISEASES 3669 \| ISG20 \| DISEASES 125 \| ADH1B \| DISEASES 6373 \| CXCL11 \| DISEASES 435 \| ASL \| DISEASES 54205 \| CYCS \| DISEASES 27087 \| B3GAT1 \| DISEASES 150684 \| COMMD1 \| DISEASES 2147 \| F2 \| DISEASES 5897 \| RAG2 \| DISEASES 344561 \| GPR148 \| DISEASES 5340 \| PLG \| DISEASES 1212 \| CLTB \| DISEASES 9537 \| TP53I11 \| DISEASES 7015 \| TERT \| DISEASES 3265 \| HRAS \| DISEASES 6868 \| ADAM17 \| DISEASES 947 \| CD34 \| DISEASES 3661 \| IRF3 \| DISEASES 9092 \| SART1 \| DISEASES 27257 \| LSM1 \| DISEASES 2286 \| FKBP2 \| DISEASES 11037 \| STON1 \| DISEASES 836 \| CASP3 \| DISEASES 2944 \| GSTM1 \| DISEASES 84868 \| HAVCR2 \| DISEASES 5319 \| PLA2G1B \| DISEASES 134083 \| OR2Y1 \| DISEASES 8837 \| CFLAR \| DISEASES 80194 \| TMEM134 \| DISEASES 3952 \| LEP \| DISEASES 3172 \| HNF4A \| DISEASES 3184 \| HNRNPD \| DISEASES 11322 \| TMC6 \| DISEASES 55075 \| UACA \| DISEASES 9153 \| SLC28A2 \| DISEASES 30835 \| CD209 \| DISEASES 6773 \| STAT2 \| DISEASES 10859 \| LILRB1 \| DISEASES 653423 \| SPAG11A \| DISEASES 23541 \| SEC14L2 \| DISEASES 10332 \| CLEC4M \| DISEASES 4233 \| MET \| DISEASES 8824 \| CES2 \| DISEASES 4684 \| NCAM1 \| DISEASES 23621 \| BACE1 \| DISEASES 7173 \| TPO \| DISEASES 26973 \| CHORDC1 \| DISEASES 84967 \| LSM10 \| DISEASES 3579 \| CXCR2 \| DISEASES 80381 \| CD276 \| DISEASES 9370 \| ADIPOQ \| DISEASES 811 \| CALR \| DISEASES 25898 \| RCHY1 \| DISEASES 4018 \| LPA \| DISEASES 51582 \| AZIN1 \| DISEASES 3615 \| IMPDH2 \| DISEASES 10611 \| PDLIM5 \| DISEASES 6014 \| RIT2 \| DISEASES 5345 \| SERPINF2 \| DISEASES 6181 \| RPLP2 \| DISEASES 3039 \| HBA1 \| DISEASES 4312 \| MMP1 \| DISEASES 26061 \| HACL1 \| DISEASES 2 \| A2M \| DISEASES 5441 \| POLR2L \| DISEASES 3309 \| HSPA5 \| DISEASES 56252 \| YLPM1 \| DISEASES 1555 \| CYP2B6 \| DISEASES 147138 \| TMC8 \| DISEASES 9622 \| KLK4 \| DISEASES 9015 \| TAF1A \| DISEASES 4843 \| NOS2 \| DISEASES 400668 \| PRSS57 \| DISEASES 29933 \| GPR132 \| DISEASES 3855 \| KRT7 \| DISEASES 6906 \| SERPINA7 \| DISEASES 50616 \| IL22 \| DISEASES 3665 \| IRF7 \| DISEASES 8651 \| SOCS1 \| DISEASES 842 \| CASP9 \| DISEASES 9021 \| SOCS3 \| DISEASES 493753 \| COA5 \| DISEASES 6401 \| SELE \| DISEASES 942 \| CD86 \| DISEASES 4088 \| SMAD3 \| DISEASES 5104 \| SERPINA5 \| DISEASES 3916 \| LAMP1 \| DISEASES 4600 \| MX2 \| DISEASES 151888 \| BTLA \| DISEASES 3043 \| HBB \| DISEASES 2152 \| F3 \| DISEASES 5133 \| PDCD1 \| DISEASES 8856 \| NR1I2 \| DISEASES 226 \| ALDOA \| DISEASES 148738 \| HFE2 \| DISEASES 114548 \| NLRP3 \| DISEASES 160851 \| DGKH \| DISEASES 3932 \| LCK \| DISEASES 7189 \| TRAF6 \| DISEASES 1576 \| CYP3A4 \| DISEASES 3824 \| KLRD1 \| DISEASES 7360 \| UGP2 \| DISEASES 2686 \| GGT7 \| DISEASES 3266 \| ERAS \| DISEASES 857 \| CAV1 \| DISEASES 5329 \| PLAUR \| DISEASES 3117 \| HLA-DQA1 \| DISEASES 4306 \| NR3C2 \| DISEASES 54681 \| P4HTM \| DISEASES 1528 \| CYB5A \| DISEASES 1544 \| CYP1A2 \| DISEASES 6692 \| SPINT1 \| DISEASES 259197 \| NCR3 \| DISEASES 3804 \| KIR2DL3 \| DISEASES 4939 \| OAS2 \| DISEASES 2537 \| IFI6 \| DISEASES 921 \| CD5 \| DISEASES 6672 \| SP100 \| DISEASES 3146 \| HMGB1 \| DISEASES 3716 \| JAK1 \| DISEASES 6318 \| SERPINB4 \| DISEASES 3455 \| IFNAR2 \| DISEASES 3605 \| IL17A \| DISEASES 285193 \| DUSP28 \| DISEASES 1499 \| CTNNB1 \| DISEASES 26762 \| HAVCR1 \| DISEASES 84706 \| GPT2 \| DISEASES 3767 \| KCNJ11 \| DISEASES 54600 \| UGT1A9 \| DISEASES 100506658 \| OCLN \| DISEASES 8764 \| TNFRSF14 \| DISEASES 355 \| FAS \| DISEASES 5265 \| SERPINA1 \| DISEASES 6720 \| SREBF1 \| DISEASES 3240 \| HP \| DISEASES 6898 \| TAT \| DISEASES 51155 \| HN1 \| DISEASES 79876 \| UBA5 \| DISEASES 11118 \| BTN3A2 \| DISEASES 801 \| CALM1 \| DISEASES 11186 \| RASSF1 \| DISEASES 60 \| ACTB \| DISEASES 9034 \| CCRL2 \| DISEASES 51390 \| AIG1 \| DISEASES 26136 \| TES \| DISEASES 6714 \| SRC \| DISEASES 1524 \| CX3CR1 \| DISEASES 6775 \| STAT4 \| DISEASES 841 \| CASP8 \| DISEASES 6364 \| CCL20 \| DISEASES 3821 \| KLRC1 \| DISEASES 9332 \| CD163 \| DISEASES 57016 \| AKR1B10 \| DISEASES 3123 \| HLA-DRB1 \| DISEASES 79947 \| DHDDS \| DISEASES 7037 \| TFRC \| DISEASES 2157 \| F8 \| DISEASES 3135 \| HLA-G \| DISEASES 5599 \| MAPK8 \| DISEASES 1066 \| CES1 \| DISEASES 6241 \| RRM2 \| DISEASES 1565 \| CYP2D6 \| DISEASES 54106 \| TLR9 \| DISEASES 6533 \| SLC6A6 \| DISEASES 6772 \| STAT1 \| DISEASES 4512 \| MT-CO1 \| DISEASES 2475 \| MTOR \| DISEASES 10724 \| MGEA5 \| DISEASES 4283 \| CXCL9 \| DISEASES 3880 \| KRT19 \| DISEASES 8678 \| BECN1 \| DISEASES 7052 \| TGM2 \| DISEASES 84284 \| NTPCR \| DISEASES 22796 \| COG2 \| DISEASES 58 \| ACTA1 \| DISEASES 142 \| PARP1 \| DISEASES 1063 \| CENPF \| DISEASES 3664 \| IRF6 \| DISEASES 1378 \| CR1 \| DISEASES 6993 \| DYNLT1 \| DISEASES 5788 \| PTPRC \| DISEASES 3075 \| CFH \| DISEASES 5743 \| PTGS2 \| DISEASES 6041 \| RNASEL \| DISEASES 462 \| SERPINC1 \| DISEASES 356 \| FASLG \| DISEASES 1805 \| DPT \| DISEASES 22926 \| ATF6 \| DISEASES 2214 \| FCGR3A \| DISEASES 1490 \| CTGF \| DISEASES 336 \| APOA2 \| DISEASES 51506 \| UFC1 \| DISEASES 912 \| CD1D \| DISEASES 922 \| CD5L \| DISEASES 632 \| BGLAP \| DISEASES 4582 \| MUC1 \| DISEASES 103 \| ADAR \| DISEASES 3570 \| IL6R \| DISEASES 6280 \| S100A9 \| DISEASES 284486 \| THEM5 \| DISEASES 79626 \| TNFAIP8L2 \| DISEASES 246269 \| LACE1 \| DISEASES 914 \| CD2 \| DISEASES 965 \| CD58 \| DISEASES 8517 \| IKBKG \| DISEASES 2316 \| FLNA \| DISEASES 8729 \| GBF1 \| DISEASES 1244 \| ABCC2 \| DISEASES 2634 \| GBP2 \| DISEASES 2633 \| GBP1 \| DISEASES 4923 \| NTSR1 \| DISEASES 2805 \| GOT1 \| DISEASES 959 \| CD40LG \| DISEASES 55361 \| PI4K2A \| DISEASES 10964 \| IFI44L \| DISEASES 1791 \| DNTT \| DISEASES 3725 \| JUN \| DISEASES 1557 \| CYP2C19 \| DISEASES 2030 \| SLC29A1 \| DISEASES 3434 \| IFIT1 \| DISEASES 3437 \| IFIT3 \| DISEASES 54558 \| SPATA6 \| DISEASES 11093 \| ADAMTS13 \| DISEASES 7422 \| VEGFA \| DISEASES 958 \| CD40 \| DISEASES 4318 \| MMP9 \| DISEASES 10864 \| SLC22A7 \| DISEASES 5328 \| PLAU \| DISEASES 27232 \| GNMT \| DISEASES 100 \| ADA \| DISEASES 84647 \| PLA2G12B \| DISEASES 2833 \| CXCR3 \| DISEASES 7099 \| TLR4 \| DISEASES 246184 \| CDC26 \| DISEASES 2790 \| GNG10 \| DISEASES 23585 \| TMEM50A \| DISEASES 1269 \| CNR2 \| DISEASES 3339 \| HSPG2 \| DISEASES 11326 \| VSIG4 \| DISEASES 249 \| ALPL \| DISEASES 229 \| ALDOB \| DISEASES 5698 \| PSMB9 \| DISEASES 5696 \| PSMB8 \| DISEASES 221527 \| ZBTB12 \| DISEASES 2155 \| F7 \| DISEASES 6850 \| SYK \| DISEASES 3055 \| HCK \| DISEASES 10673 \| TNFSF13B \| DISEASES 79070 \| KDELC1 \| DISEASES 50943 \| FOXP3 \| DISEASES 100507436 \| MICA \| DISEASES 3107 \| HLA-C \| DISEASES 64078 \| SLC28A3 \| DISEASES 7133 \| TNFRSF1B \| DISEASES 3190 \| HNRNPK \| DISEASES 4524 \| MTHFR \| DISEASES 3105 \| HLA-A \| DISEASES 23412 \| COMMD3 \| DISEASES 1471 \| CST3 \| DISEASES 10537 \| UBD \| DISEASES 114798 \| SLITRK1 \| DISEASES 7056 \| THBD \| DISEASES 3604 \| TNFRSF9 \| DISEASES 8718 \| TNFRSF25 \| DISEASES 4609 \| MYC \| DISEASES 414062 \| CCL3L3 \| DISEASES 3980 \| LIG3 \| DISEASES 9308 \| CD83 \| DISEASES 29103 \| DNAJC15 \| DISEASES 1906 \| EDN1 \| DISEASES 9636 \| ISG15 \| DISEASES 4739 \| NEDD9 \| DISEASES 444 \| ASPH \| DISEASES 1543 \| CYP1A1 \| DISEASES 23586 \| DDX58 \| DISEASES 25820 \| ARIH1 \| DISEASES 203102 \| ADAM32 \| DISEASES 3559 \| IL2RA \| DISEASES 10346 \| TRIM22 \| DISEASES 3704 \| ITPA \| DISEASES 3440 \| IFNA2 \| DISEASES 3456 \| IFNB1 \| DISEASES 551 \| AVP \| DISEASES 6462 \| SHBG \| DISEASES 3030 \| HADHA \| DISEASES 51284 \| TLR7 \| DISEASES 1646 \| AKR1C2 \| DISEASES 1645 \| AKR1C1 \| DISEASES 3486 \| IGFBP3 \| DISEASES 4267 \| CD99 \| DISEASES 90865 \| IL33 \| DISEASES 29126 \| CD274 \| DISEASES 3822 \| KLRC2 \| DISEASES 91543 \| RSAD2 \| DISEASES 51091 \| SEPSECS \| DISEASES 93492 \| TPTE2 \| DISEASES 6736 \| SRY \| DISEASES 51280 \| GOLM1 \| DISEASES 3875 \| KRT18 \| DISEASES 55576 \| STAB2 \| DISEASES 238 \| ALK \| DISEASES 53345 \| TM6SF2 \| DISEASES 28227 \| PPP2R3B \| DISEASES 3811 \| KIR3DL1 \| DISEASES 51070 \| NOSIP \| DISEASES 250 \| ALPP \| DISEASES 29994 \| BAZ2B \| DISEASES 12 \| SERPINA3 \| DISEASES 10018 \| BCL2L11 \| DISEASES 114898 \| C1QTNF2 \| DISEASES 2719 \| GPC3 \| DISEASES 130 \| ADH6 \| DISEASES 2875 \| GPT \| DISEASES 6696 \| SPP1 \| DISEASES 3965 \| LGALS9 \| DISEASES 2643 \| GCH1 \| DISEASES 4239 \| MFAP4 \| DISEASES 2919 \| CXCL1 \| DISEASES 174 \| AFP \| DISEASES 6387 \| CXCL12 \| DISEASES 10379 \| IRF9 \| DISEASES 4780 \| NFE2L2 \| DISEASES 80380 \| PDCD1LG2 \| DISEASES 10407 \| SPAG11B \| DISEASES 4599 \| MX1 \| DISEASES 2950 \| GSTP1 \| DISEASES 10410 \| IFITM3 \| DISEASES 8091 \| HMGA2 \| DISEASES 6654 \| SOS1 \| DISEASES 23119 \| HIC2 \| DISEASES 60489 \| APOBEC3G \| DISEASES 728441 \| GGT2 \| DISEASES 2011 \| MARK2 \| DISEASES 7018 \| TF \| DISEASES 1363 \| CPE \| DISEASES 7852 \| CXCR4 \| DISEASES 23066 \| CAND2 \| DISEASES 2641 \| GCG \| DISEASES 4938 \| OAS1 \| DISEASES 5601 \| MAPK9 \| DISEASES 3481 \| IGF2 \| DISEASES 3113 \| HLA-DPA1 \| DISEASES 197 \| AHSG \| DISEASES 9689 \| BZW1 \| DISEASES 1029 \| CDKN2A \| DISEASES 720 \| C4A \| DISEASES 55665 \| URGCP \| DISEASES 22893 \| BAHD1 \| DISEASES 960 \| CD44 \| DISEASES 3702 \| ITK \| DISEASES 7124 \| TNF \| DISEASES 7264 \| TSTA3 \| DISEASES 3106 \| HLA-B \| DISEASES 10165 \| SLC25A13 \| DISEASES 4615 \| MYD88 \| DISEASES 57506 \| MAVS \| DISEASES 4049 \| LTA \| DISEASES 9465 \| AKAP7 \| DISEASES 388372 \| CCL4L1 \| DISEASES 3115 \| HLA-DPB1 \| DISEASES 1154 \| CISH \| DISEASES 834 \| CASP1 \| DISEASES 4050 \| LTB \| DISEASES 6424 \| SFRP4 \| DISEASES 3451 \| IFNA17 \| DISEASES 3586 \| IL10 \| DISEASES 3441 \| IFNA4 \| DISEASES 55758 \| RCOR3 \| DISEASES 3077 \| HFE \| DISEASES 338376 \| IFNE \| DISEASES 54659 \| UGT1A3 \| DISEASES 4700 \| NDUFA6 \| DISEASES 5478 \| PPIA \| DISEASES 10209 \| EIF1 \| DISEASES 30816 \| ERVW-1 \| DISEASES 2649 \| NR6A1 \| DISEASES 131 \| ADH7 \| DISEASES 51428 \| DDX41 \| DISEASES 26064 \| RAI14 \| DISEASES 2920 \| CXCL2 \| DISEASES 503542 \| SPRN \| DISEASES 930 \| CD19 \| DISEASES 3684 \| ITGAM \| DISEASES 7421 \| VDR \| DISEASES 8972 \| MGAM \| DISEASES 1649 \| DDIT3 \| DISEASES 374569 \| ASPG \| DISEASES 567 \| B2M \| DISEASES 101 \| ADAM8 \| DISEASES 3949 \| LDLR \| DISEASES 10607 \| TBL3 \| DISEASES 11201 \| POLI \| DISEASES 7138 \| TNNT1 \| DISEASES 284424 \| MIR7-3HG \| DISEASES 246734 \| NPCDR1 \| DISEASES 6023 \| RMRP \| DISEASES 26800 \| SNORD49A \| DISEASES
Locus	(Waiting for update.)

Disease ID	540
Disease	hepatitis
Integrated Phenotype	(Waiting for update.)
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:285) HP:0001394 \| Hepatic cirrhosis \| 357 HP:0001402 \| Hepatocellular carcinoma \| 267 HP:0030731 \| Carcinoma \| 261 HP:0001399 \| Liver failure \| 87 HP:0001397 \| Hepatic steatosis \| 66 HP:0001395 \| Hepatic fibrosis \| 59 HP:0001873 \| Low platelet count \| 37 HP:0002665 \| Lymphoma \| 35 HP:0000716 \| Depression \| 34 HP:0001903 \| Anemia \| 33 HP:0000855 \| Insulin resistance \| 31 HP:0000952 \| Yellow skin \| 30 HP:0001396 \| Cholestasis \| 28 HP:0200123 \| Chronic liver inflammation \| 28 HP:0002896 \| Liver cancer \| 27 HP:0006554 \| Acute hepatic failure \| 26 HP:0001945 \| Fever \| 24 HP:0002633 \| Vasculitis \| 21 HP:0100778 \| Cryoglobulinemia \| 21 HP:0001878 \| Haemolytic anaemia \| 17 HP:0001369 \| Arthritis \| 16 HP:0002910 \| Elevated transaminases \| 16 HP:0001919 \| Acute renal failure \| 16 HP:0002664 \| Neoplasia \| 16 HP:0002721 \| Immunodeficiency \| 16 HP:0000083 \| Renal insufficiency \| 16 HP:0000819 \| Diabetes mellitus \| 15 HP:0001370 \| Rheumatoid arthritis \| 14 HP:0001890 \| Autoimmune hemolytic anemia \| 14 HP:0012378 \| Fatigue \| 14 HP:0004448 \| Fulminant hepatic failure \| 13 HP:0012622 \| Chronic kidney disease \| 13 HP:0000099 \| Glomerular nephritis \| 12 HP:0003774 \| End-stage renal failure \| 12 HP:0000112 \| Nephropathy \| 11 HP:0001909 \| Leukemia \| 11 HP:0005523 \| Lymphoproliferative disorder \| 11 HP:0012115 \| Liver inflammation \| 11 HP:0012189 \| Hodgkin disease \| 10 HP:0100626 \| Chronic hepatic failure \| 10 HP:0003765 \| Psoriasis \| 10 HP:0002960 \| Autoimmune condition \| 9 HP:0030153 \| Cholangiocarcinoma \| 9 HP:0100646 \| Thyroiditis \| 9 HP:0002608 \| Celiac disease \| 9 HP:0000822 \| Hypertension \| 9 HP:0001875 \| Neutropenia \| 8 HP:0030151 \| Cholangitis \| 8 HP:0002090 \| Pneumonia \| 7 HP:0200119 \| Acute liver inflammation \| 7 HP:0012578 \| Membranous glomerulonephritis \| 7 HP:0003002 \| Breast carcinoma \| 7 HP:0012531 \| Pain \| 7 HP:0001298 \| Encephalopathy \| 7 HP:0001513 \| Obesity \| 7 HP:0001541 \| Ascites \| 7 HP:0005550 \| Chronic lymphatic leukemia \| 7 HP:0012191 \| B-cell lymphoma \| 6 HP:0001410 \| Decreased liver function \| 6 HP:0002480 \| Hepatic encephalopathy \| 6 HP:0001082 \| Cholecystitis \| 6 HP:0002716 \| Lymph node hyperplasia \| 5 HP:0001287 \| Meningitis \| 5 HP:0010783 \| Erythema \| 5 HP:0000979 \| Purpura \| 5 HP:0002360 \| Sleep disturbance \| 5 HP:0012410 \| Pure red cell aplasia \| 5 HP:0002613 \| Biliary cirrhosis \| 5 HP:0002621 \| Atherosclerosis \| 4 HP:0100033 \| Tic disorder \| 4 HP:0001735 \| Acute pancreatitis \| 4 HP:0003198 \| Myopathic changes \| 4 HP:0001733 \| Pancreatic inflammation \| 4 HP:0002904 \| High blood bilirubin levels \| 4 HP:0001138 \| Damaged optic nerve \| 4 HP:0001915 \| Aplastic anemia \| 4 HP:0006775 \| Multiple myeloma \| 4 HP:0001028 \| Strawberry mark \| 4 HP:0001635 \| Congestive heart failure \| 4 HP:0001406 \| Intrahepatic cholestasis \| 4 HP:0000093 \| Proteinuria \| 4 HP:0001973 \| Autoimmune thrombocytopenia \| 3 HP:0001409 \| Portal hypertension \| 3 HP:0001876 \| Low blood cell count \| 3 HP:0002861 \| Melanoma \| 3 HP:0002605 \| Hepatic necrosis \| 3 HP:0002202 \| Pleural effusion \| 3 HP:0000793 \| Membranoproliferative glomerulonephritis \| 3 HP:0000820 \| Thyroid abnormality \| 3 HP:0000488 \| Noninflammatory retina disease \| 3 HP:0000100 \| Nephrosis \| 3 HP:0000739 \| Anxiety \| 3 HP:0012539 \| Non-Hodgkin lymphoma \| 3 HP:0001971 \| Hypersplenism \| 3 HP:0100806 \| Sepsis \| 3 HP:0002586 \| Peritonitis \| 3 HP:0000708 \| Behavioral problems \| 3 HP:0010702 \| Hypergammaglobulinaemia \| 3 HP:0011034 \| Amyloid disease \| 3 HP:0100543 \| Cognitive deficits \| 3 HP:0100653 \| Optic neuritis \| 3 HP:0003256 \| Coagulopathy \| 3 HP:0002148 \| Hypophosphataemia \| 3 HP:0100280 \| Morbus Crohn \| 3 HP:0001880 \| Eosinophilia \| 3 HP:0001941 \| acidemia \| 3 HP:0012486 \| Inflammation of spinal cord \| 3 HP:0002583 \| Colitis \| 3 HP:0001677 \| Coronary artery disease \| 3 HP:0006573 \| Acute fatty liver \| 2 HP:0009830 \| Peripheral neuritis \| 2 HP:0200120 \| Chronic active hepatitis \| 2 HP:0100512 \| Vitamin D deficiency \| 2 HP:0002099 \| Asthma \| 2 HP:0100522 \| Thymoma \| 2 HP:0002014 \| Diarrhea \| 2 HP:0012119 \| Methemoglobinemia \| 2 HP:0003473 \| Fatigable weakness \| 2 HP:0003493 \| Elevated antinuclear antibody \| 2 HP:0003073 \| Hypoalbuminaemia \| 2 HP:0000956 \| Keratosis nigricans \| 2 HP:0000872 \| Hashimoto's thyroiditis \| 2 HP:0001943 \| Hypoglycemia \| 2 HP:0002894 \| Neoplasia of the pancreas \| 2 HP:0012532 \| Chronic pain \| 2 HP:0012190 \| T cell lymphoma \| 2 HP:0004905 \| Vitamin A deficiency \| 2 HP:0001009 \| Telangiectases \| 2 HP:0012324 \| Myeloid leukemia \| 2 HP:0001414 \| Microvesicular hepatic steatosis \| 2 HP:0000989 \| pruritis \| 2 HP:0005528 \| Bone marrow hypoplasia \| 2 HP:0000789 \| Infertility \| 2 HP:0000821 \| Underactive thyroid \| 2 HP:0001824 \| Weight loss \| 2 HP:0004787 \| Fulminant hepatitis \| 2 HP:0010628 \| Facial palsy, unilateral or bilateral \| 2 HP:0100665 \| Angiooedema \| 2 HP:0006515 \| Interstitial pneumonitis \| 2 HP:0004808 \| Acute myelogenous leukemia \| 2 HP:0006562 \| Viral hepatitis \| 2 HP:0011945 \| Cryptogenic organizing pneumonia \| 2 HP:0002829 \| Arthralgias \| 2 HP:0001404 \| Hepatocellular necrosis \| 2 HP:0002383 \| Encephalitis \| 2 HP:0005110 \| Atrial fibrillation \| 2 HP:0012234 \| Agranulocytosis \| 2 HP:0003613 \| Antiphospholipid antibodies \| 2 HP:0100633 \| Inflammation of the esophagus \| 2 HP:0100279 \| Ulcerative colitis \| 2 HP:0001324 \| Muscular weakness \| 2 HP:0000217 \| Dry mouth syndrome \| 2 HP:0000969 \| Dropsy \| 2 HP:0000833 \| Glucose intolerance \| 2 HP:0002240 \| Enlarged liver \| 2 HP:0100324 \| Progressive systemic scleroderma \| 2 HP:0002027 \| Abdominal pain \| 2 HP:0002908 \| Conjugated hyperbilirubinemia \| 2 HP:0002725 \| Systemic lupus erythematosus \| 2 HP:0002955 \| Granulomatosis \| 2 HP:0001259 \| Coma \| 2 HP:0003074 \| High blood glucose \| 2 HP:0003128 \| Lactic acidosis \| 2 HP:0006721 \| Acute lymphocytic leukemia \| 2 HP:0003251 \| Male infertility \| 2 HP:0000105 \| Renal enlargement \| 1 HP:0000726 \| Dementia \| 1 HP:0001511 \| Prenatal onset growth retardation \| 1 HP:0012174 \| Glioblastoma multiforme \| 1 HP:0000763 \| Sensory neuropathy \| 1 HP:0001988 \| hypoglycemia, recurrent \| 1 HP:0100809 \| Scalp tenderness \| 1 HP:0005364 \| Severe viral infections \| 1 HP:0100845 \| Anaphylactic shock \| 1 HP:0005521 \| Disseminated intravascular coagulation \| 1 HP:0009831 \| Single damaged nerve \| 1 HP:0002239 \| Gastrointestinal hemorrhage \| 1 HP:0001300 \| Parkinsonism \| 1 HP:0004420 \| Arterial thrombosis \| 1 HP:0001433 \| Enlarged liver and spleen \| 1 HP:0100753 \| Schizophrenia \| 1 HP:0006510 \| Chronic obstructive pulmonary disease \| 1 HP:0100843 \| Glioblastoma \| 1 HP:0100614 \| Muscle inflammation \| 1 HP:0009726 \| Renal neoplasm \| 1 HP:0001978 \| Extramedullary hematopoiesis \| 1 HP:0011227 \| Elevated C-reactive protein level \| 1 HP:0012594 \| High urine albumin levels \| 1 HP:0000157 \| Abnormality of the tongue \| 1 HP:0000135 \| Hypogonadism \| 1 HP:0002039 \| Anorexia \| 1 HP:0012309 \| Cutaneous amyloidosis \| 1 HP:0006580 \| Portal fibrosis \| 1 HP:0000505 \| Poor vision \| 1 HP:0005202 \| Helicobacter pylori infection \| 1 HP:0012432 \| Chronic fatigue \| 1 HP:0002863 \| Myelodysplastic syndrome \| 1 HP:0030248 \| Blood clot in mesentertic vein \| 1 HP:0002273 \| Tetraparesis \| 1 HP:0003324 \| Muscle weakness, diffuse \| 1 HP:0030242 \| Blood clot in portal vein \| 1 HP:0002013 \| Emesis \| 1 HP:0100658 \| Bacterial infection of skin \| 1 HP:0004943 \| Accelerated atherosclerosis \| 1 HP:0001403 \| Macrovesicular steatosis \| 1 HP:0012215 \| Testicular microlithiasis \| 1 HP:0005435 \| Impaired T cell function \| 1 HP:0000123 \| Nephritis \| 1 HP:0004395 \| Malnutrition \| 1 HP:0001025 \| Hives \| 1 HP:0100805 \| Precocious menopause \| 1 HP:0001894 \| Thrombocytosis \| 1 HP:0010543 \| Opsoclonus \| 1 HP:0001336 \| Myoclonic jerks \| 1 HP:0100537 \| Inflammation of the fascia \| 1 HP:0002352 \| Leukoencephalopathy \| 1 HP:0003281 \| Increased ferritin \| 1 HP:0000717 \| Autism \| 1 HP:0001658 \| Myocardial infarction \| 1 HP:0009125 \| Lipodystrophy \| 1 HP:0011892 \| Vitamin K deficiency \| 1 HP:0002902 \| Hyponatremia \| 1 HP:0100651 \| Type I diabetes mellitus \| 1 HP:0000853 \| Goitre \| 1 HP:0100749 \| Thoracic pain \| 1 HP:0000836 \| Overactive thyroid \| 1 HP:0000802 \| Erectile dysfunction \| 1 HP:0001271 \| Polyneuropathy \| 1 HP:0001892 \| Bleeding diathesis \| 1 HP:0004836 \| Acute promyelocytic leukemia \| 1 HP:0001048 \| Cavernous angioma \| 1 HP:0008198 \| Congenital hypoparathyroidism \| 1 HP:0001907 \| Thromboembolic disease \| 1 HP:0002719 \| infections, recurrent \| 1 HP:0000572 \| Visual loss \| 1 HP:0002018 \| Nausea \| 1 HP:0007417 \| Discoid lupus erythematosus \| 1 HP:0001744 \| Splenomegaly \| 1 HP:0004936 \| Blood clot in vein \| 1 HP:0002092 \| Pulmonary artery hypertension \| 1 HP:0011950 \| Bronchiolitis \| 1 HP:0012579 \| Minimal change glomerulonephritis \| 1 HP:0011787 \| Central hypothyroidism \| 1 HP:0009027 \| Foot drop \| 1 HP:0002617 \| Aneurysmal dilatation \| 1 HP:0000670 \| Dental caries \| 1 HP:0000843 \| Hyperparathyroidism \| 1 HP:0200044 \| Porokeratosis \| 1 HP:0006560 \| Bile duct hyperplasia \| 1 HP:0001297 \| Cerebral vascular events \| 1 HP:0002615 \| Low blood pressure \| 1 HP:0005994 \| Nodular goiter \| 1 HP:0000518 \| Cataract \| 1 HP:0002459 \| Dysautonomia \| 1 HP:0007256 \| Abnormal pyramidal signs \| 1 HP:0001413 \| Micronodular cirrhosis \| 1 HP:0002860 \| Squamous cell carcinoma \| 1 HP:0012156 \| Hemophagocytosis \| 1 HP:0002584 \| Intestinal hemorrhage \| 1 HP:0000845 \| Acromegalic growth \| 1 HP:0002020 \| Heartburn \| 1 HP:0000999 \| Pyoderma \| 1 HP:0100827 \| Lymphocytosis \| 1 HP:0003077 \| Hyperlipidemia \| 1 HP:0001045 \| Blotchy loss of skin color \| 1 HP:0001371 \| Flexion contractures of joints \| 1 HP:0000790 \| Hematuria \| 1 HP:0011947 \| Respiratory infection \| 1 HP:0000729 \| Pervasive developmental disorder \| 1 HP:0001888 \| Lymphocytopenia \| 1 HP:0009064 \| Generalized lipodystrophy \| 1 HP:0012819 \| Myocarditis \| 1 HP:0100820 \| Glomerulopathy \| 1 HP:0010310 \| Chylothorax \| 1 HP:0100545 \| Arterial stenosis \| 1 HP:0012126 \| Gastric cancer \| 1 HP:0001250 \| Seizures \| 1 HP:0001791 \| Fetal ascites \| 1 HP:0012592 \| Albuminuria \| 1 HP:0000554 \| Uveitis \| 1 HP:0000939 \| Osteoporosis \| 1 HP:0003202 \| Neurogenic muscle atrophy, especially in the lower limbs \| 1 HP:0003306 \| Spinal rigidity \| 1 HP:0000360 \| Ringing in the ears \| 1 HP:0002301 \| Hemiplegia \| 1

Disease ID	540
Disease	hepatitis
Manually Symptom	(Waiting for update.)
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:64) C0009450 \| infection \| 1297 C0151317 \| chronic infection \| 332 C0023890 \| cirrhosis \| 299 C0019204 \| hepatocellular carcinoma \| 264 C0239946 \| liver fibrosis \| 187 C0021311 \| infections \| 168 C0023890 \| liver cirrhosis \| 66 C0085605 \| liver failure \| 60 C0341439 \| chronic liver disease \| 47 C1264606 \| persistent infection \| 40 C0040034 \| thrombocytopenia \| 36 C0011570 \| depression \| 34 C0008370 \| cholestasis \| 28 C0022346 \| jaundice \| 26 C0023895 \| liver diseases \| 25 C0162557 \| acute liver failure \| 22 C0038826 \| superinfection \| 16 C0003864 \| arthritis \| 16 C0021051 \| immunodeficiency \| 15 C0796095 \| c syndrome \| 14 C0042749 \| viremia \| 14 C0275518 \| acute infection \| 13 C0442874 \| neuropathy \| 12 C0162557 \| fulminant hepatic failure \| 12 C0017658 \| glomerulonephritis \| 12 C0022658 \| nephropathy \| 11 C0022660 \| acute renal failure \| 8 C0034362 \| q fever \| 7 C0008325 \| cholecystitis \| 6 C0009450 \| infectious diseases \| 6 C0034902 \| pure red cell aplasia \| 5 C0034150 \| purpura \| 5 C0282193 \| iron overload \| 4 C0008372 \| intrahepatic cholestasis \| 4 C0162557 \| acute hepatic failure \| 4 C0002874 \| aplastic anemia \| 4 C0036323 \| schistosomiasis \| 4 C0030305 \| pancreatitis \| 4 C0001339 \| acute pancreatitis \| 4 C0020541 \| portal hypertension \| 3 C0019204 \| hepatocellular carcinomas \| 3 C0002878 \| haemolytic anaemia \| 3 C0151798 \| hepatic necrosis \| 3 C0032227 \| pleural effusion \| 3 C0027726 \| nephrotic syndrome \| 3 C0085274 \| parvovirus b19 \| 3 C0031117 \| peripheral neuropathy \| 2 C0036285 \| scarlet fever \| 2 C0023890 \| cirrhosis of the liver \| 2 C0473221 \| cryoglobulinemic glomerulonephritis \| 2 C0014059 \| acute disseminated encephalomyelitis \| 2 C0030312 \| bone marrow failure \| 2 C0043117 \| immune thrombocytopenic purpura \| 1 C0040149 \| subacute thyroiditis \| 1 C0149520 \| acute cholecystitis \| 1 C0162839 \| porokeratosis \| 1 C0017920 \| glucose-6-phosphate dehydrogenase deficiency \| 1 C0343190 \| cutaneous polyarteritis nodosa \| 1 C0149985 \| secondary syphilis \| 1 C0012739 \| disseminated intravascular coagulation \| 1 C0005779 \| coagulation disorders \| 1 C0024291 \| hemophagocytic syndrome \| 1 C0042109 \| urticaria \| 1 C0422833 \| ent symptoms \| 1

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:12)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs1042522	23564481	7157	TP53	umls:C0019158	BeFree	Subgroup analyses by source of controls and hepatitis virus infection status further demonstrated the significant association, whereas stratification factors involving gender and family history of HCC did not modify the association between p53 codon 72 Arg/Pro polymorphism and HCC risk.	0.002985861	2013	TP53	17	7676154	G	T,C
rs10484389	25705159	401237	CASC15	umls:C0019158	GWASCAT	Genome-wide association study of hepatitis in korean populations.	0.12	2014	CASC15	6	22075033	C	T
rs10853728	23469142	3627	CXCL10	umls:C0019158	BeFree	In HBeAg-positive patients (n = 48), HBV viral load correlated with active hepatitis, while in HBeAg-negative patients (n = 67), rs10853728 CC genotype (p = 0.032) and a trend of higher IP-10 levels (p = 0.092) were associated with active hepatitis.	0.000814326	2013	NA	19	39254506	C	G,T
rs11025185	25705159	89797	NAV2	umls:C0019158	GWASCAT	Genome-wide association study of hepatitis in korean populations.	0.12	2014	NAV2	11	19572259	G	A
rs11540654	23564481	7157	TP53	umls:C0019158	BeFree	Subgroup analyses by source of controls and hepatitis virus infection status further demonstrated the significant association, whereas stratification factors involving gender and family history of HCC did not modify the association between p53 codon 72 Arg/Pro polymorphism and HCC risk.	0.002985861	2013	TP53	17	7676040	C	T,G,A
rs12979860	24085431	282617	IFNL3	umls:C0019158	BeFree	In the overall analysis, the IL-28B rs12979860 T/C polymorphism was identified as a genetic risk factor for hepatitis virus-related HCC and LC development.	0.001357209	2014	IFNL3;IFNL4	19	39248147	C	T
rs1432133	25705159	2567	GABRG3	umls:C0019158	GWASCAT	Genome-wide association study of hepatitis in korean populations.	0.12	2014	GABRG3	15	26983199	A	G
rs25487	23780894	7515	XRCC1	umls:C0019158	BeFree	Our meta-analysis of the available data did not find an obvious effect of XRCC1 Arg399Gln polymorphism on hepatitis-related hepatocellular carcinoma.	0.005276948	2013	XRCC1	19	43551574	T	C
rs386493716	23780894	7515	XRCC1	umls:C0019158	BeFree	Our meta-analysis of the available data did not find an obvious effect of XRCC1 Arg399Gln polymorphism on hepatitis-related hepatocellular carcinoma.	0.005276948	2013	NA	NA	NA	NA	NA
rs386545618	24155211	4524	MTHFR	umls:C0019158	BeFree	Associations between MTHFR Ala222Val polymorphism and risks of hepatitis and hepatitis-related liver cancer: a meta-analysis.	0.000271442	2013	NA	NA	NA	NA	NA
rs4467099	25705159	400499	LOC400499	umls:C0019158	GWASCAT	Genome-wide association study of hepatitis in korean populations.	0.12	2014	LOC400499	16	11449038	C	T
rs8014067	25705159	83851	SYT16	umls:C0019158	GWASCAT	Genome-wide association study of hepatitis in korean populations.	0.12	2014	SYT16	14	62086539	A	T

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:501)
CHR	POS	SNPID	REF	ALT	ORI_SNPID	PMID	P_VALUE	P_VALUE_TEXT	OR/BETA	CI95_TEXT	GWAS_INITIAL_SAMPLE_SIZE	SUB_POPULATION	SUPER_POPULATION	GWAS_TRAIT	HPO_ID	HPO_TERM	DO_ID	DO_TERM	MESH_ID	MESH_TERM	EFO_ID	EFO_TERM	DOLITE_TERM	RISK_ALLELE	PUBLICATION_TYPE	AA	GENE_SYMBOL	TYPE	REFGENE
1	10385471	rs17401966	A	G	rs17401966	21750111	1.70E-18	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	KIF1B
2	27730940	rs1260326	T	C	rs1260326	21750111	4.36E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	GCKR
2	112770770	rs4374383	A	G	rs4374383	22841784	1.00E-09	(Duration F0-1/F3-4, transfused)	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs4374383-A	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
2	120271783	rs2579612	C	T	rs2579612	24162738	1.14E-06	GWAS stage only	2.33	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2579612-G	Research Support, Non-U.S. Gov't	T	SCTR
2	209757798	rs3851939	C	T	rs3851939	21764829	6.73E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
2	219279097	rs7607369	A	G	rs7607369	21764829	6.08E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	45922691	rs9842595	G	A,T	rs9842595	21764829	1.90E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	59899215	rs294457	A	G	rs294457	21764829	2.09E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	71001255	rs6789153	C	G	rs6789153	21750111	9.20E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
3	133109606	rs16840309	T	C	rs16840309	23321320	5.32E-06	NA	NA	NA	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	NA	Research Support, Non-U.S. Gov't	T	TMEM108
3	141463298	rs16851720	A	C	rs16851720	22841784	9.00E-09	QTF	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs16851720-C	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
3	184090266	rs6141	C	T	rs6141	21750111	5.38E-11	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	THPO
4	101896676	rs12649554	T	C	rs12649554	21750111	4.80E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
4	107769255	rs11943338	A	G	rs11943338	24768677	4.30E-04	NA	1.5	[1.20-1.70]	649 European ancestry cases; 13,436 European ancestry controls	European(14085)	ALL(14085)	EUR(14085)	ALL(14085)	Autoimmune hepatitis type-1	HPOID:0012115	Hepatitis	DOID:2048	autoimmune hepatitis	NA	NA	NA	NA	NA	NA	Multicenter Study	Research Support, Non-U.S. Gov't	A
4	171813485	rs17056316	A	G	rs17056316	24162738	5.00E-09	GWAS stage only	2.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs17056316-A	Research Support, Non-U.S. Gov't	A	NA
5	38056753	rs10512674	A	C	rs10512674	23321320	5.58E-06	NA	NA	NA	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	NA	Research Support, Non-U.S. Gov't	C	NA
5	38059375	rs6891116	C	A	rs6891116	23321320	9.14E-06	NA	NA	NA	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	NA	Research Support, Non-U.S. Gov't	C	NA
6	30822413	rs3095345	C	T	rs3095345	21750111	3.28E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	30897022	rs2517459	T	C	rs2517459	21750111	8.98E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	31222119	rs9264227	G	A	rs9264227	24162738	8.62E-06	GWAS stage only,Imputed	1.5	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264227-G	Research Support, Non-U.S. Gov't	G	NA
6	31229845	rs9264411	C	T	rs111894719	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111894719-C	Research Support, Non-U.S. Gov't	C	NA
6	31229921	rs9264412	G	C	rs113597160	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113597160-G	Research Support, Non-U.S. Gov't	C	NA
6	31229930	rs9264413	C	T	rs111496944	24162738	1.63E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111496944-C	Research Support, Non-U.S. Gov't	T	NA
6	31229942	rs9264414	T	C	rs112378983	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112378983-T	Research Support, Non-U.S. Gov't	C	NA
6	31230078	rs9264417	A	G	rs112784298	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112784298-A	Research Support, Non-U.S. Gov't	G	NA
6	31230356	rs9264427	G	A	rs113634302	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113634302-G	Research Support, Non-U.S. Gov't	A	NA
6	31230452	rs9264428	C	A	rs112919433	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112919433-C	Research Support, Non-U.S. Gov't	A	NA
6	31230498	rs9264429	G	A	rs113229690	24162738	3.46E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113229690-G	Research Support, Non-U.S. Gov't	G,A	NA
6	31230605	rs4995903	C	T	rs113776386	24162738	2.90E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113776386-C	Research Support, Non-U.S. Gov't	T,C	NA
6	31230645	rs4995902	C	T	rs111307939	24162738	3.46E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111307939-C	Research Support, Non-U.S. Gov't	C,T	NA
6	31230651	rs4995901	G	C	rs111500196	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111500196-G	Research Support, Non-U.S. Gov't	C	NA
6	31230759	rs2394951	A	G	rs111681215	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111681215-A	Research Support, Non-U.S. Gov't	G,A	NA
6	31230882	rs2394952	G	A	rs112451075	24162738	3.10E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112451075-G	Research Support, Non-U.S. Gov't	A,G	NA
6	31231193	rs9264450	A	G	rs78626708	24162738	3.13E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs78626708-A	Research Support, Non-U.S. Gov't	G,A	NA
6	31231199	rs9264451	C	T	rs79148176	24162738	2.80E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs79148176-C	Research Support, Non-U.S. Gov't	T	NA
6	31231232	rs9264452	G	A	rs115330136	24162738	3.29E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115330136-G	Research Support, Non-U.S. Gov't	A	NA
6	31231382	rs9264455	T	A	rs9264455	24162738	4.48E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264455-T	Research Support, Non-U.S. Gov't	T	NA
6	31231688	rs9264466	T	C	rs144873769	24162738	4.00E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs144873769-T	Research Support, Non-U.S. Gov't	C,T	NA
6	31231718	rs4365966	C	A	rs151244225	24162738	9.60E-07	GWAS stage only,Imputed	1.62	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs151244225-C	Research Support, Non-U.S. Gov't	A	NA
6	31231809	rs3130445	T	C	rs112914760	24162738	2.05E-06	GWAS stage only,Imputed	1.59	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112914760-T	Research Support, Non-U.S. Gov't	C,T	NA
6	31232111	rs3130542	A	G	rs3130542	24162738	9.00E-14	NA	1.33	[1.23-1.44]	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs3130542-A	Research Support, Non-U.S. Gov't	G	NA
6	31232147	rs3130543	C	T	rs111725653	24162738	2.88E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111725653-C	Research Support, Non-U.S. Gov't	T,C	NA
6	31232318	rs9264481	T	C	rs77768065	24162738	1.66E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs77768065-T	Research Support, Non-U.S. Gov't	T,C	NA
6	31232412	rs9264482	T	G	rs9264482	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264482-T	Research Support, Non-U.S. Gov't	G	NA
6	31232446	rs9264483	T	C	rs9264483	24162738	4.25E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264483-T	Research Support, Non-U.S. Gov't	C,T	NA
6	31232543	rs2844623	C	T	rs2844623	21764829	5.91E-08	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31232563	rs9264489	C	G	rs9264489	24162738	4.21E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264489-C	Research Support, Non-U.S. Gov't	G	NA
6	31232676	rs9264492	T	A,G	rs9264492	24162738	4.61E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264492-T	Research Support, Non-U.S. Gov't	G	NA
6	31232697	rs9264493	A	G	rs9264493	24162738	5.44E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264493-A	Research Support, Non-U.S. Gov't	G,A	NA
6	31232703	rs9264494	A	G	rs112355258	24162738	4.88E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112355258-A	Research Support, Non-U.S. Gov't	G	NA
6	31232769	rs9264497	G	A	rs74689645	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs74689645-G	Research Support, Non-U.S. Gov't	A	NA
6	31232789	rs9264498	A	T	rs113899804	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113899804-A	Research Support, Non-U.S. Gov't	T	NA
6	31232825	rs9264500	G	A	rs112369944	24162738	4.25E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112369944-G	Research Support, Non-U.S. Gov't	A	NA
6	31232913	rs9264502	C	T	rs113146917	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113146917-C	Research Support, Non-U.S. Gov't	T	NA
6	31233121	rs9264505	T	C	rs112986645	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112986645-T	Research Support, Non-U.S. Gov't	C	NA
6	31233143	rs9264506	C	T	rs111520353	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111520353-C	Research Support, Non-U.S. Gov't	C	NA
6	31233152	rs9264507	A	G	rs113792953	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113792953-A	Research Support, Non-U.S. Gov't	G,A	NA
6	31233214	rs9264508	T	C	rs111948891	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111948891-T	Research Support, Non-U.S. Gov't	T,C	NA
6	31233258	rs549189246	G	C	rs112118931	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112118931-G	Research Support, Non-U.S. Gov't	C	NA
6	31233258	rs9264511	G	C	rs112118931	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112118931-G	Research Support, Non-U.S. Gov't	C	NA
6	31233270	rs2894202	T	G	rs111692722	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111692722-T	Research Support, Non-U.S. Gov't	G	NA
6	31233353	rs2394953	G	A	rs112278495	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112278495-G	Research Support, Non-U.S. Gov't	G	NA
6	31233456	rs2394956	C	T	rs112640680	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112640680-C	Research Support, Non-U.S. Gov't	T	NA
6	31233521	rs2394957	T	C	rs113016391	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113016391-T	Research Support, Non-U.S. Gov't	C	NA
6	31233529	rs2394958	T	C	rs111480208	24162738	5.10E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111480208-T	Research Support, Non-U.S. Gov't	C	NA
6	31233529	rs560512392	T	C	rs111480208	24162738	5.10E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111480208-T	Research Support, Non-U.S. Gov't	C	NA
6	31233643	rs571519400	T	C	rs112002603	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112002603-T	Research Support, Non-U.S. Gov't	C,T	NA
6	31233643	rs9264522	T	C	rs112002603	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112002603-T	Research Support, Non-U.S. Gov't	C,T	NA
6	31233758	rs9264523	T	A	rs116602847	24162738	4.34E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116602847-T	Research Support, Non-U.S. Gov't	A	NA
6	31233845	rs9264524	T	G	rs114123711	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114123711-T	Research Support, Non-U.S. Gov't	T	NA
6	31233988	rs9264526	G	T	rs112355686	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112355686-G	Research Support, Non-U.S. Gov't	T,G	NA
6	31233992	rs9264527	C	T	rs112650453	24162738	4.83E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112650453-C	Research Support, Non-U.S. Gov't	C,T	NA
6	31234058	rs9264528	A	G	rs112832332	24162738	3.61E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112832332-A	Research Support, Non-U.S. Gov't	A	NA
6	31234074	rs9264529	G	A	rs111598000	24162738	3.61E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111598000-G	Research Support, Non-U.S. Gov't	G	NA
6	31234771	rs9264548	A	G	rs9264548	24162738	7.41E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9264548-A	Research Support, Non-U.S. Gov't	G	NA
6	31235127	rs9264559	T	C	rs111492590	24162738	4.65E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111492590-T	Research Support, Non-U.S. Gov't	C	NA
6	31235139	rs9264560	T	C	rs111524359	24162738	5.71E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111524359-T	Research Support, Non-U.S. Gov't	C	NA
6	31235276	rs6929779	C	T	rs113825473	24162738	1.37E-06	GWAS stage only,Imputed	1.61	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113825473-C	Research Support, Non-U.S. Gov't	T	NA
6	31235421	rs9264570	C	T	rs111725566	24162738	1.93E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111725566-C	Research Support, Non-U.S. Gov't	C,T	NA
6	31235502	rs571022361	T	TA	rs111715660	24162738	6.09E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111715660-T	Research Support, Non-U.S. Gov't	A	NA
6	31235502	rs9264572	T	A	rs111715660	24162738	6.09E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111715660-T	Research Support, Non-U.S. Gov't	A	NA
6	31235558	rs6907910	A	G	rs111954877	24162738	5.10E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111954877-A	Research Support, Non-U.S. Gov't	G	NA
6	31235576	rs9264575	G	C	rs112499813	24162738	5.10E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112499813-G	Research Support, Non-U.S. Gov't	C	NA
6	31235610	rs6907622	C	A	rs111430987	24162738	2.14E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111430987-C	Research Support, Non-U.S. Gov't	A,C	NA
6	31235708	rs9264578	C	G	rs113905965	24162738	4.43E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs113905965-C	Research Support, Non-U.S. Gov't	G,C	NA
6	31235786	rs9264581	C	T	rs115390162	24162738	4.22E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115390162-C	Research Support, Non-U.S. Gov't	T	NA
6	31235816	rs9264582	A	G	rs114661772	24162738	3.80E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114661772-A	Research Support, Non-U.S. Gov't	G,A	NA
6	31236316	rs2524098	G	T	rs114001460	24162738	5.16E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114001460-G	Research Support, Non-U.S. Gov't	A	HLA-C
6	31236339	rs2524097	T	C	rs116687300	24162738	5.20E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116687300-T	Research Support, Non-U.S. Gov't	G	HLA-C
6	31237124	rs1130838	T	C	rs115114271	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115114271-T	Research Support, Non-U.S. Gov't	G	HLA-C
6	31237162	rs35708511	C	G	rs116716035	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116716035-C	Research Support, Non-U.S. Gov't	G	HLA-C
6	31237323	rs68094471	A	G	rs114212090	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114212090-A	Research Support, Non-U.S. Gov't	G	HLA-C
6	31237333	rs66772001	T	A	rs115399944	24162738	6.93E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115399944-T	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237353	rs67827555	T	C	rs115111251	24162738	7.29E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115111251-T	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237405	rs56010430	C	T	rs115987759	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115987759-C	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237437	rs66459704	T	C	rs116816228	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116816228-T	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237449	rs68037221	T	C	rs115614955	24162738	3.48E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115614955-T	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237463	rs66620546	C	G	rs115651989	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115651989-C	Research Support, Non-U.S. Gov't	NA	HLA-C
6	31237563	rs3819287	C	T	rs116173008	24162738	6.84E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116173008-C	Research Support, Non-U.S. Gov't	A	HLA-C
6	31237592	rs9264606	A	C	rs115690024	24162738	6.84E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115690024-A	Research Support, Non-U.S. Gov't	C,A	HLA-C
6	31237660	rs9264608	A	C,G,T	rs114481632	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114481632-A	Research Support, Non-U.S. Gov't	A,G	HLA-C
6	31237664	rs9264609	C	T	rs114629030	24162738	8.31E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114629030-C	Research Support, Non-U.S. Gov't	T	HLA-C
6	31237786	rs41556617	A	T	rs116111058	24162738	3.81E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116111058-A	Research Support, Non-U.S. Gov't	A	HLA-C
6	31238230	rs1050716	G	C,T	rs116229259	24162738	6.80E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116229259-G	Research Support, Non-U.S. Gov't	G	HLA-C
6	31238234	rs1050344	G	A	rs115445355	24162738	2.34E-06	GWAS stage only,Imputed	1.59	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115445355-G	Research Support, Non-U.S. Gov't	C	HLA-C
6	31238259	rs1131096	G	C,T	rs115500469	24162738	2.47E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115500469-G	Research Support, Non-U.S. Gov't	C	HLA-C
6	31238297	rs9264636	C	T	rs114408626	24162738	2.83E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114408626-C	Research Support, Non-U.S. Gov't	C	HLA-C
6	31238308	rs9264637	G	C	rs115055805	24162738	2.83E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115055805-G	Research Support, Non-U.S. Gov't	G	HLA-C
6	31238318	rs9264638	G	A	rs115509556	24162738	2.94E-06	GWAS stage only,Imputed	1.58	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115509556-G	Research Support, Non-U.S. Gov't	G	HLA-C
6	31238372	rs9264640	C	G	rs115694990	24162738	8.28E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115694990-C	Research Support, Non-U.S. Gov't	G	HLA-C
6	31238490	rs9264642	T	C	rs114921580	24162738	9.18E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114921580-T	Research Support, Non-U.S. Gov't	C	HLA-C
6	31238492	rs9264643	C	A	rs115819304	24162738	7.72E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115819304-C	Research Support, Non-U.S. Gov't	A	HLA-C
6	31238524	rs9264645	G	A	rs116742693	24162738	8.02E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116742693-G	Research Support, Non-U.S. Gov't	A	HLA-C
6	31238535	rs9264646	T	C	rs114403438	24162738	9.39E-06	GWAS stage only,Imputed	1.54	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114403438-T	Research Support, Non-U.S. Gov't	T,C	HLA-C
6	31238762	rs9264652	T	C	rs115024771	24162738	6.64E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115024771-T	Research Support, Non-U.S. Gov't	T,C	HLA-C
6	31239205	rs9264663	C	T	rs114878632	24162738	3.17E-06	GWAS stage only,Imputed	1.57	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114878632-C	Research Support, Non-U.S. Gov't	T	HLA-C
6	31239855	rs7767581	C	G	rs115148805	24162738	5.45E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115148805-C	Research Support, Non-U.S. Gov't	G	HLA-C
6	31240180	rs2524093	A	C	rs115987915	24162738	4.60E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115987915-A	Research Support, Non-U.S. Gov't	G	HLA-C
6	31240293	rs2524091	C	A,G,T	rs115054748	24162738	5.16E-06	GWAS stage only,Imputed	1.55	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115054748-C	Research Support, Non-U.S. Gov't	T	HLA-C
6	31240721	rs2249742	C	T	rs2249742	21764829	3.35E-09	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31242089	rs2524080	A	T	rs111980301	24162738	1.91E-06	GWAS stage only,Imputed	1.61	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs111980301-A	Research Support, Non-U.S. Gov't	T	NA
6	31242151	rs2844620	C	T	rs115212502	24162738	1.11E-06	GWAS stage only,Imputed	1.49	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115212502-C	Research Support, Non-U.S. Gov't	A	NA
6	31242560	rs3132490	G	A	rs150061230	24162738	2.98E-06	GWAS stage only,Imputed	1.62	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs150061230-G	Research Support, Non-U.S. Gov't	T	NA
6	31243971	rs2844612	A	G	rs112206327	24162738	1.32E-06	GWAS stage only,Imputed	1.62	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112206327-A	Research Support, Non-U.S. Gov't	C	NA
6	31243979	rs2844611	T	A	rs112992781	24162738	1.32E-06	GWAS stage only,Imputed	1.62	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs112992781-T	Research Support, Non-U.S. Gov't	A	NA
6	31244021	rs2524074	G	A	rs2524074	24162738	1.32E-06	GWAS stage only,Genotyped	1.62	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2524074-G	Research Support, Non-U.S. Gov't	C	NA
6	31248434	rs9264758	A	G	rs142658973	24162738	1.24E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs142658973-A	Research Support, Non-U.S. Gov't	G	NA
6	31249132	rs9264761	A	T	rs114609171	24162738	4.40E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114609171-A	Research Support, Non-U.S. Gov't	T	NA
6	31249196	rs9264763	A	C	rs141711945	24162738	4.47E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs141711945-A	Research Support, Non-U.S. Gov't	C	NA
6	31263510	rs2524143	T	C	rs115805175	24162738	4.97E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115805175-T	Research Support, Non-U.S. Gov't	G	NA
6	31263522	rs2524142	C	G	rs116162078	24162738	4.97E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116162078-C	Research Support, Non-U.S. Gov't	C	NA
6	31264133	rs2524139	G	C	rs114038118	24162738	4.97E-06	GWAS stage only,Imputed	1.6	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114038118-G	Research Support, Non-U.S. Gov't	G	NA
6	31264582	rs2524137	C	T	rs116820827	24162738	1.25E-06	GWAS stage only,Imputed	1.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116820827-C	Research Support, Non-U.S. Gov't	A	NA
6	31265135	rs2524129	C	G	rs116030749	24162738	1.26E-06	GWAS stage only,Imputed	1.65	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116030749-C	Research Support, Non-U.S. Gov't	C	NA
6	31265490	rs2247056	T	C	rs2247056	24162738	1.24E-06	GWAS stage only,Genotyped	1.65	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2247056-T	Research Support, Non-U.S. Gov't	C	NA
6	31267422	rs2524060	A	C	rs115108000	24162738	6.69E-07	GWAS stage only,Imputed	1.67	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115108000-A	Research Support, Non-U.S. Gov't	G	NA
6	31271567	rs7750963	A	G	rs114389012	24162738	9.36E-07	GWAS stage only,Imputed	1.66	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114389012-A	Research Support, Non-U.S. Gov't	G	NA
6	31272261	rs6457374	C	T	rs115845232	24162738	1.20E-06	GWAS stage only,Imputed	1.65	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115845232-C	Research Support, Non-U.S. Gov't	T	NA
6	31350802	rs2844533	G	A	rs2844533	21750111	4.76E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	31367865	rs2523454	G	A	rs2523454	21764829	6.07E-09	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31446546	rs2248373	T	C	rs2248373	21750111	1.15E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	NA	NA
6	31602967	rs1046089	G	A	rs1046089	21764829	1.18E-09	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31603770	rs11229	A	G	rs11229	21764829	3.92E-16	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31613739	rs3130048	T	C	rs3130048	21764829	2.98E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31616366	rs805303	G	A	rs805303	21764829	2.08E-09	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31619576	rs3117583	A	G	rs3117583	21764829	2.44E-16	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31632134	rs3130618	C	A	rs3130618	21764829	8.22E-16	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31639979	rs9267532	C	T	rs9267532	21764829	8.98E-17	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31673436	rs9267546	G	A	rs9267546	21764829	2.56E-15	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31687008	rs1065356	G	A	rs1065356	21764829	1.01E-14	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31764899	rs480092	T	C	rs480092	21764829	5.95E-13	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31815723	rs12210887	G	T	rs12210887	21750111	3.36E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	31837277	rs660550	C	A	rs660550	21764829	1.74E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31851234	rs652888	A	G	rs652888	21764829	3.15E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31870856	rs9267665	C	T	rs9267665	21764829	1.00E-17	NA	2.05	[1.64-2.57]	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31920873	rs4151664	C	T	rs4151664	21764829	4.89E-16	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	31933518	rs492899	T	C	rs492899	21750111	7.80E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	SKIV2L
6	32026808	rs12198173	G	A	rs12198173	21764829	1.08E-10	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32066765	rs13199524	C	T	rs13199524	21764829	1.70E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32074804	rs12153855	T	C	rs12153855	21764829	2.09E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32109979	rs204999	A	G	rs204999	21750111	3.76E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32109979	rs204999	A	G	rs204999	21764829	1.69E-15	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32145205	rs3134947	C	T	rs3134947	21764829	1.82E-14	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32146492	rs3134945	C	A	rs3134945	21764829	1.21E-13	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32147696	rs3130349	G	A	rs3130349	21764829	2.19E-12	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32155581	rs204993	A	G	rs204993	21750111	7.25E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	PBX2
6	32161324	rs12663103	T	C	rs12663103	21750111	6.09E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	GPSM3
6	32168771	rs3134942	G	T	rs3134942	21764829	1.19E-10	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32185605	rs2854050	G	A	rs2854050	21750111	2.76E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NOTCH4
6	32315727	rs910049	T	C	rs910049	23321320	9.00E-11	NA	1.46	[1.28-1.62]	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	rs910049-A	Research Support, Non-U.S. Gov't	G	C6orf10
6	32339076	rs2050190	A	G	rs2050190	21764829	7.51E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32348145	rs2395157	A	G	rs2395157	21764829	4.72E-17	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32354428	rs4424066	A	G	rs4424066	21764829	1.24E-17	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32358270	rs3117099	G	A	rs3117099	21764829	1.72E-10	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32366421	rs4248166	T	C	rs4248166	21764829	2.37E-17	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32368087	rs3817963	T	C	rs3817963	21764829	9.20E-18	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32368087	rs3817963	T	C	rs3817963	23321320	1.00E-08	NA	1.3	[1.18-1.42]	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	rs3817963-A	Research Support, Non-U.S. Gov't	A	BTNL2
6	32376746	rs3763316	C	T	rs3763316	24282030	3.75E-13	NA	1.84	[1.56-2.17]	108 Han Chinese ancestry high-responder cases; 77 Han Chinese ancestry non-responder controls	Han Chinese(185)	ALL(185)	ASN(185)	ALL(185)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	rs3763316-T	Research Support, Non-U.S. Gov't	Comparative Study	C
6	32379736	rs9405098	G	A	rs9405098	23321320	1.00E-10	NA	1.37	[1.24-1.51]	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	rs9405098-A	Research Support, Non-U.S. Gov't	G	NA
6	32383108	rs9268528	A	G	rs9268528	21764829	8.30E-12	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32384721	rs9268542	A	G	rs9268542	21764829	5.43E-12	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32389648	rs3135363	A	G	rs3135363	21750111	2.17E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32389648	rs3135363	A	G	rs3135363	21764829	7.00E-22	NA	1.53	[1.35-1.74]	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32389648	rs3135363	A	G	rs3135363	23321320	1.00E-10	NA	1.37	[1.24-1.51]	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	rs3135363-C	Research Support, Non-U.S. Gov't	C	NA
6	32389648	rs3135363	A	G	rs3135363	24282030	8.00E-07	NA	1.51	[1.28-1.78]	108 Han Chinese ancestry high-responder cases; 77 Han Chinese ancestry non-responder controls	Han Chinese(185)	ALL(185)	ASN(185)	ALL(185)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Research Support, Non-U.S. Gov't	Comparative Study	C
6	32401079	rs3129860	A	G	rs3129860	23321320	1.00E-09	NA	1.36	[1.22-1.49]	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	rs3129860-A	Research Support, Non-U.S. Gov't	G	NA
6	32404135	rs5000563	A	G	rs5000563	21750111	5.60E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	32404878	rs2395174	T	G	rs2395174	21750111	4.44E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	32404878	rs2395174	T	G	rs2395174	21764829	7.70E-17	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32560859	rs28366298	A	C	rs28366298	24282030	1.67E-14	NA	1.77	[1.53-2.05]	108 Han Chinese ancestry high-responder cases; 77 Han Chinese ancestry non-responder controls	Han Chinese(185)	ALL(185)	ASN(185)	ALL(185)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	rs28366298-C	Research Support, Non-U.S. Gov't	Comparative Study	A
6	32569691	rs477515	G	A	rs477515	21764829	6.44E-15	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32569691	rs477515	G	A	rs477515	24282030	3.00E-19	NA	2.05	[1.75-2.41]	108 Han Chinese ancestry high-responder cases; 77 Han Chinese ancestry non-responder controls	Han Chinese(185)	ALL(185)	ASN(185)	ALL(185)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	rs477515-T	Research Support, Non-U.S. Gov't	Comparative Study	C
6	32570400	rs2516049	T	C	rs2516049	21764829	2.90E-15	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32570400	rs2516049	T	C	rs2516049	23321320	6.45E-06	NA	NA	NA	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	NA	Research Support, Non-U.S. Gov't	A	LOC100507709
6	32572251	rs2858870	T	C	rs2858870	21764829	3.01E-13	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32577380	rs660895	A	G	rs660895	21764829	1.79E-14	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32582796	rs13204672	A	G	rs13204672	24282030	1.45E-13	NA	2.01	[1.67-2.43]	108 Han Chinese ancestry high-responder cases; 77 Han Chinese ancestry non-responder controls	Han Chinese(185)	ALL(185)	ASN(185)	ALL(185)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	rs13204672-G	Research Support, Non-U.S. Gov't	Comparative Study	A
6	32605884	rs2187668	C	T	rs2187668	24768677	2.00E-78	NA	2.9	[2.60-3.40]	649 European ancestry cases; 13,436 European ancestry controls	European(14085)	ALL(14085)	EUR(14085)	ALL(14085)	Autoimmune hepatitis type-1	HPOID:0012115	Hepatitis	DOID:2048	autoimmune hepatitis	NA	NA	NA	NA	NA	NA	Multicenter Study	Research Support, Non-U.S. Gov't	G
6	32650587	rs17205696	C	T	rs115550381	24162738	4.66E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115550381-T	Research Support, Non-U.S. Gov't	C	NA
6	32651117	rs9275141	T	G	rs9275141	21750111	1.42E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32652317	rs7755224	A	G,T	rs7755224	21750111	2.24E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	32653018	rs28371251	T	C	rs115048082	24162738	5.50E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115048082-C	Research Support, Non-U.S. Gov't	T	NA
6	32657578	rs7774434	T	C	rs7774434	21764829	5.88E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	32658429	rs9368737	T	C	rs114139590	24162738	6.55E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114139590-C	Research Support, Non-U.S. Gov't	T	NA
6	32669373	rs11752643	C	T	rs11752643	21750111	1.26E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32669767	rs2647050	T	C	rs2647050	21750111	4.71E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	32670000	rs2858308	G	T	rs2858308	21750111	3.36E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32670255	rs2856718	C	T	rs2856718	21750111	4.00E-37	NA	1.56	[1.45-1.67]	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2856718-A	Research Support, Non-U.S. Gov't	G	NA
6	32670956	rs2856705	C	T	rs2856705	21750111	3.47E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32675067	rs17206350	T	C	rs115659749	24162738	3.73E-06	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115659749-C	Research Support, Non-U.S. Gov't	T	NA
6	32680970	rs7745656	G	T	rs7745656	21750111	1.26E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32681631	rs9275596	C	T	rs9275596	21750111	1.70E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T,C	NA
6	32682174	rs3104404	C	A	rs3104404	21750111	2.63E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32682308	rs3104405	C	A	rs3104405	21750111	1.81E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	32682862	rs3892710	C	T	rs3892710	21750111	3.95E-04	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	32698457	rs9276162	G	A	rs9276162	21750111	5.78E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	32705276	rs13199787	C	T	rs13199787	21750111	2.53E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32706334	rs7773694	A	G	rs7773694	21750111	3.83E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32706478	rs7755596	C	T	rs7755596	21750111	2.58E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	32707295	rs9276370	G	T	rs9276370	21750111	6.88E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	HLA-DQA2
6	32718162	rs9276482	C	T	rs115764021	24162738	5.23E-06	GWAS stage only,Imputed	1.75	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115764021-T	Research Support, Non-U.S. Gov't	T	MIR3135B
6	32722767	rs6934041	C	G	rs114762770	24162738	1.34E-06	GWAS stage only,Imputed	1.79	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114762770-G	Research Support, Non-U.S. Gov't	G	NA
6	32725193	rs2301271	A	G	rs2301271	21750111	2.96E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	HLA-DQB2
6	32729642	rs762815	G	C	rs116291161	24162738	6.47E-06	GWAS stage only,Imputed	1.72	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116291161-C	Research Support, Non-U.S. Gov't	G	HLA-DQB2
6	32729821	rs7768538	C	A	rs115275824	24162738	5.81E-06	GWAS stage only,Imputed	1.72	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115275824-A	Research Support, Non-U.S. Gov't	C	HLA-DQB2
6	32729880	rs9276583	G	A	rs114232243	24162738	5.81E-06	GWAS stage only,Imputed	1.72	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114232243-A	Research Support, Non-U.S. Gov't	G	HLA-DQB2
6	32730012	rs7453920	A	G	rs7453920	21750111	6.00E-28	NA	1.81	[1.62-2.01]	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7453920-G	Research Support, Non-U.S. Gov't	G	HLA-DQB2
6	32730012	rs7453920	A	G	rs7453920	24162738	5.00E-37	NA	1.89	[1.69-2.08]	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7453920-G	Research Support, Non-U.S. Gov't	G	HLA-DQB2
6	32730086	rs2051549	G	A	rs114535641	24162738	5.81E-06	GWAS stage only,Imputed	1.72	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114535641-A	Research Support, Non-U.S. Gov't	T	HLA-DQB2
6	32736936	rs6901084	C	T	rs6901084	21750111	1.55E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32739888	rs1383265	T	C	rs1383265	21750111	3.77E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32763110	rs2621377	C	T	rs2621377	21750111	4.77E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	32798548	rs1042116	G	A	rs1042116	21750111	4.52E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	TAP2
6	32900651	rs154972	A	G	rs154972	21750111	1.46E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32900718	rs181997	G	A	rs181997	21750111	1.13E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	32981848	rs9276991	A	G	rs9276991	21750111	3.38E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	32987774	rs423639	C	T	rs423639	21750111	3.38E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33026246	rs2395309	A	G	rs2395309	19349983	1.16E-13	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G,A	NA
6	33026246	rs2395309	A	G	rs2395309	21750111	1.28E-16	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G,A	NA
6	33026246	rs2395309	A	G	rs2395309	21764829	1.26E-07	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33033022	rs3077	A	G	rs3077	19349983	1.59E-13	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33033022	rs3077	A	G	rs3077	21750111	2.00E-61	NA	1.87	[1.73-2.01]	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs3077-G	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33033022	rs3077	A	G	rs3077	21764829	4.47E-08	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33033022	rs3077	A	G	rs3077	22737229	1.00E-09	Clearance of HBV	1.67	[1.43-2.00]	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	rs3077-C	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33033022	rs3077	A	G	rs3077	22737229	4.00E-45	Protective effects against CHB	1.82	[1.67-1.96]	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	rs3077-C	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33034596	rs2301226	G	A	rs2301226	21750111	1.71E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33034815	rs1367728	G	A	rs1367728	21750111	2.44E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	HLA-DPA1
6	33035877	rs9469341	A	G	rs9469341	21750111	1.28E-16	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	HLA-DPA1
6	33035877	rs9469341	A	G	rs9469341	21764829	1.03E-07	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33038766	rs2301220	C	T	rs2301220	19349983	1.81E-13	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	HLA-DPA1
6	33038766	rs2301220	C	T	rs2301220	21750111	1.38E-16	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	HLA-DPA1
6	33039625	rs9277341	T	C	rs9277341	19349983	1.84E-08	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33039625	rs9277341	T	C	rs9277341	21750111	1.47E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33039625	rs9277341	T	C	rs9277341	21764829	2.19E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33041034	rs1431399	A	C,G,T	rs1431399	21750111	3.26E-16	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	HLA-DPA1
6	33041034	rs1431399	A	C,G,T	rs1431399	21764829	1.12E-10	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33045558	rs3135021	G	A	rs3135021	19349983	1.63E-08	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G,A	HLA-DPA1
6	33045558	rs3135021	G	A	rs3135021	21750111	7.24E-13	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G,A	HLA-DPA1
6	33047031	rs1431403	T	C	rs1431403	22737229	8.97E-16	NA	NA	NA	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33047432	rs2856822	A	C	rs114396961	24162738	3.62E-07	GWAS stage only,Imputed	1.49	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114396961-C	Research Support, Non-U.S. Gov't	C	HLA-DPA1
6	33048686	rs1042169	G	A,T	rs116369303	24162738	7.77E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116369303-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33048694	rs553665868	A	G	rs115008006	24162738	8.11E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115008006-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33048921	rs7770370	A	G	rs116679521	24162738	2.56E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116679521-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33049211	rs928976	C	T	rs114115575	24162738	1.45E-06	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114115575-T	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33050829	rs9277392	G	C	rs114918174	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114918174-C	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33050877	rs9277393	A	G	rs115668285	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115668285-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33050970	rs9277394	A	T	rs114393291	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114393291-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33051051	rs9277395	A	G	rs116791231	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116791231-G	Research Support, Non-U.S. Gov't	A,G	HLA-DPB1
6	33051277	rs9277397	A	G	rs116651593	24162738	9.71E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116651593-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33051280	rs9277398	T	C	rs114049315	24162738	9.71E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114049315-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33051394	rs9277401	C	T	rs116425814	24162738	8.83E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116425814-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33051554	rs9277406	T	C	rs115688984	24162738	4.30E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115688984-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33051562	rs9277408	G	A	rs115238630	24162738	4.85E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115238630-A	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33051624	rs9277409	C	G	rs115810879	24162738	4.74E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115810879-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33051640	rs9277410	G	A	rs116255670	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116255670-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33051683	rs9277411	C	T	rs115190895	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115190895-T	Research Support, Non-U.S. Gov't	C,T	HLA-DPB1
6	33051689	rs9277412	C	T	rs116739017	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116739017-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33051790	rs9277420	C	A	rs115295510	24162738	5.77E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115295510-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33051845	rs9277423	T	A	rs116021664	24162738	3.22E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116021664-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33051865	rs9277424	A	C	rs115470008	24162738	5.14E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115470008-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33051969	rs9277427	A	T	rs114818321	24162738	5.53E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114818321-T	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33051976	rs9277428	T	A	rs116653007	24162738	4.02E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116653007-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052028	rs9277431	C	T	rs115863713	24162738	5.08E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115863713-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052072	rs9277432	A	T	rs116193012	24162738	4.53E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116193012-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052128	rs9277433	C	T	rs114775991	24162738	4.53E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114775991-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052250	rs9277437	A	G	rs116735198	24162738	4.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116735198-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052303	rs9277438	C	T	rs114384365	24162738	2.66E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114384365-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052315	rs9277439	C	A	rs116460236	24162738	2.97E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116460236-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052327	rs9277440	C	T	rs115940431	24162738	2.63E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115940431-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052354	rs9277441	C	A	rs116508927	24162738	4.91E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116508927-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052382	rs1811359	G	C	rs116035345	24162738	5.28E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116035345-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33052414	rs9277443	A	G	rs145619190	24162738	3.49E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs145619190-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052439	rs9277444	A	G	rs115475053	24162738	5.20E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115475053-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33052498	rs9277446	G	C	rs115537548	24162738	7.86E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115537548-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33052768	rs1042187	T	A,C,G	rs114009083	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114009083-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33052803	rs1042212	G	A	rs114642386	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114642386-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33052950	rs1042331	T	C	rs115866623	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115866623-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33052958	rs1042335	C	T	rs116283696	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116283696-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33052986	rs1071597	T	C	rs115288819	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115288819-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33053167	rs9277458	A	C	rs114398048	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114398048-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33053248	rs9277459	A	G	rs115440545	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115440545-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33053252	rs9277460	G	A	rs116471469	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116471469-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33053307	rs9277463	C	T	rs116633022	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116633022-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33053396	rs9277465	A	G	rs115755801	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115755801-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33053399	rs9277466	T	C	rs115424889	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115424889-C	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33053444	rs9277467	G	A,C	rs115105101	24162738	4.79E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115105101-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33053455	rs9277468	C	T	rs115603897	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115603897-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33053477	rs9277470	G	C	rs116592890	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116592890-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33053968	rs9277490	T	A	rs114926188	24162738	1.55E-06	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114926188-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33053982	rs9277492	G	C	rs116449581	24162738	4.06E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116449581-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33054057	rs9277494	G	A	rs116603005	24162738	3.17E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116603005-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054457	rs1042544	A	G	rs114717252	24162738	2.88E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114717252-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33054619	rs929	G	A	rs114385226	24162738	7.70E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114385226-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054711	rs9277532	G	T	rs114899534	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114899534-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33054807	rs9277534	A	G	rs115967922	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115967922-G	Research Support, Non-U.S. Gov't	A,G	HLA-DPB1
6	33054861	rs9277535	A	G	rs114459399	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114459399-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054861	rs9277535	A	G	rs9277535	19349983	6.00E-39	NA	1.75	[1.61-1.92]	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9277535-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054861	rs9277535	A	G	rs9277535	21750111	3.00E-54	NA	1.77	[1.65-1.91]	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9277535-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054861	rs9277535	A	G	rs9277535	21764829	3.00E-12	NA	1.39	[1.23-1.59]	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33054861	rs9277535	A	G	rs9277535	22737229	2.00E-17	Clearance of HBV	1.52	[1.37-1.67]	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9277535-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054861	rs9277535	A	G	rs9277535	22737229	2.00E-21	Protective effects against CHB	1.64	[1.47-1.82]	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9277535-G	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33054890	rs9277536	C	T	rs115107409	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115107409-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33055009	rs9277537	C	A	rs114782971	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114782971-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33055123	rs9277540	A	G	rs116735758	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116735758-G	Research Support, Non-U.S. Gov't	G	HLA-DPB1
6	33055158	rs9277541	A	G	rs114289471	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114289471-G	Research Support, Non-U.S. Gov't	A,G	HLA-DPB1
6	33055247	rs9277542	T	C	rs115854500	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115854500-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33055247	rs9277542	T	C	rs9277542	22737229	3.98E-15	NA	NA	NA	181 East Asian ancestry HBV carriers; 184 East Asian ancestry controls; 185 East Asian ancestry spontaneously HBV-resolved individuals	East Asian(550)	ALL(550)	ASN(550)	ALL(550)	Hepatitis B (viral clearance)	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33055308	rs9277544	C	T	rs115973003	24162738	6.01E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115973003-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33055487	rs9277550	T	C	rs116649724	24162738	5.86E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116649724-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33055494	rs9277551	G	T	rs116087639	24162738	5.86E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116087639-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33055516	rs9277553	T	C	rs114195294	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114195294-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33055538	rs9277554	C	T	rs9277554	21750111	1.87E-17	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33055538	rs9277554	C	T	rs9277554	21764829	3.08E-11	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33055780	rs3128963	C	T	rs115186402	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115186402-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33055818	rs3128964	A	G	rs116737096	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116737096-G	Research Support, Non-U.S. Gov't	G,A	HLA-DPB1
6	33056207	rs3130186	C	T	rs116335534	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116335534-T	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33056253	rs3128968	T	A	rs116790970	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116790970-A	Research Support, Non-U.S. Gov't	A	HLA-DPB1
6	33056405	rs3130187	C	T	rs114150262	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114150262-T	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33056566	rs3091281	T	C	rs114068262	24162738	7.25E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs114068262-C	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33056711	rs9277558	C	T	rs115864736	24162738	6.98E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115864736-T	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33056897	rs9277565	C	T	rs9277565	21750111	2.81E-15	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33056916	rs9277566	G	T	rs115533527	24162738	5.90E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115533527-T	Research Support, Non-U.S. Gov't	T	HLA-DPB1
6	33057055	rs9277568	T	C	rs116771249	24162738	8.67E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs116771249-C	Research Support, Non-U.S. Gov't	C	HLA-DPB1
6	33058952	rs10484569	G	A	rs10484569	19349983	2.34E-08	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33058952	rs10484569	G	A	rs10484569	21750111	2.14E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33059996	rs3128917	T	G	rs3128917	19349983	1.98E-10	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33059996	rs3128917	T	G	rs3128917	21750111	2.81E-15	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33060118	rs2281388	G	A	rs2281388	19349983	3.62E-08	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	33060118	rs2281388	G	A	rs2281388	21750111	2.72E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	33060892	rs2295118	C	T	rs115913474	24162738	3.58E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115913474-T	Research Support, Non-U.S. Gov't	T	NA
6	33060949	rs3117222	C	T	rs3117222	19349983	1.29E-10	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	33060949	rs3117222	C	T	rs3117222	21750111	5.23E-15	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	33061098	rs3128918	T	C	rs3128918	21750111	2.05E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33063403	rs3117216	A	G	rs115679387	24162738	3.58E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115679387-G	Research Support, Non-U.S. Gov't	C	NA
6	33066594	rs2894316	A	G	rs115986757	24162738	7.66E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115986757-G	Research Support, Non-U.S. Gov't	G	NA
6	33066594	rs559802496	A	G	rs115986757	24162738	7.66E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs115986757-G	Research Support, Non-U.S. Gov't	G	NA
6	33074963	rs3130215	A	G	rs3130215	21750111	4.08E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33077776	rs6457713	C	T	rs6457713	21750111	2.39E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33079166	rs9380343	C	T	rs9380343	19349983	1.66E-08	NA	NA	NA	179 Japanese ancestry cases; 934 Japanese ancestry controls	Japanese(1113)	ALL(1113)	ASN(1113)	ALL(1113)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	HLA-DPB2
6	33079166	rs9380343	C	T	rs9380343	21750111	1.66E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	HLA-DPB2
6	33085851	rs3117039	C	T	rs3117039	21750111	6.80E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	33086249	rs3117035	C	T	rs3117035	21764829	2.43E-09	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	33125725	rs9277920	G	A	rs9277920	21750111	3.12E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	33173842	rs439205	G	A	rs439205	21750111	2.55E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	HSD17B8
6	33174783	rs421446	A	G	rs421446	21750111	1.02E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	33179689	rs2854028	C	T	rs2854028	21750111	1.48E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	RING1
6	33184894	rs9277937	T	C	rs9277937	21750111	1.90E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33480435	rs86715	A	G	rs86715	21750111	8.08E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33480738	rs68191	T	C	rs68191	21750111	1.51E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33548394	rs5745568	G	T	rs5745568	21750111	6.66E-11	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	NA
6	33595399	rs4711332	A	G	rs4711332	21750111	6.44E-08	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	ITPR3
6	33630472	rs2296340	G	A	rs2296340	21750111	3.08E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	ITPR3
6	33679807	rs3818532	A	G	rs3818532	21750111	2.51E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	NA
6	33787746	rs13203745	T	C	rs13203745	21750111	3.81E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	33828234	rs10947460	G	A	rs10947460	21750111	1.13E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	33847077	rs10947463	G	A	rs10947463	21750111	3.55E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
6	35502202	rs9380516	T	C	rs9380516	22841784	5.00E-07	(Duration F0-1/F3-4, male)	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs9380516-T	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
6	52861204	rs3756979	T	G	rs3756979	24162738	1.56E-08	GWAS stage only	2.33	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs3756979-A	Research Support, Non-U.S. Gov't	A	NA
6	135418635	rs7775698	C	T	rs7775698	21750111	2.54E-14	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
6	159959673	rs555627	G	A	rs555627	24162738	1.12E-08	GWAS stage only	2.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs555627-G	Research Support, Non-U.S. Gov't	C	NA
7	32820437	rs10243492	A	G	rs10243492	24162738	1.97E-07	GWAS stage only	1.48	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs10243492-A	Research Support, Non-U.S. Gov't	G	NA
7	47779969	rs7800244	G	T	rs7800244	22841784	3.00E-06	Binary F0-1/F3-4	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs7800244-T	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
7	135293128	rs4294134	A	G	rs4294134	21750111	2.07E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NUP205
7	140863646	rs1012435	G	A	rs1012435	21750111	1.38E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	LOC100507421
8	134616136	rs2978048	T	G	rs2978048	24503447	1.00E-06	NA	0.25	[NA] unit increase	176 European ancestry individuals	European(176)	ALL(176)	EUR(176)	ALL(176)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	NA	NA	NA	NA	Hepatitis C	NA	Research Support, Non-U.S. Gov't	T	NA
9	4763176	rs385893	T	C	rs385893	21750111	2.95E-13	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
9	93181531	rs883924	G	A	rs883924	22841784	2.00E-06	(Duration F0-1/F3-4,>20yo)	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs883924-A	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
10	96769769	rs1934975	A	G	rs1934975	21750111	6.79E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	NA
11	89990909	rs1962137	T	G	rs1962137	21750111	2.15E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
12	104421808	rs2629751	A	G	rs2629751	22841784	1.00E-07	Binary F0/F4	NA	NA	1,161 European ancestry HCV-infected individuals	European(1161)	ALL(1161)	EUR(1161)	ALL(1161)	Hepatitis C induced liver fibrosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D019698	Hepatitis C, Chronic	EFOID:0001422	hepatitis C infection	Hepatitis C	rs2629751-G	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
12	111884608	rs3184504	T	C	rs3184504	24768677	8.00E-08	NA	1.4	[1.20-1.60]	649 European ancestry cases; 13,436 European ancestry controls	European(14085)	ALL(14085)	EUR(14085)	ALL(14085)	Autoimmune hepatitis type-1	HPOID:0012115	Hepatitis	DOID:2048	autoimmune hepatitis	NA	NA	NA	NA	NA	NA	Multicenter Study	Research Support, Non-U.S. Gov't	C
12	111887659	rs739496	A	G	rs739496	21750111	4.75E-19	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	SH2B3
12	112110489	rs3782886	T	C	rs3782886	21750111	5.49E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	BRAP
12	112241766	rs671	G	A	rs671	21750111	4.50E-09	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	ALDH2
12	126534862	rs10847046	G	A	rs10847046	21750111	2.73E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
12	126537580	rs10773227	G	A	rs10773227	21750111	3.11E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
12	126543165	rs7312063	G	A	rs7312063	21750111	2.38E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
13	27978642	rs2760902	G	A	rs2760902	21764829	1.12E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
13	107936790	rs9587342	G	A	rs9587342	21764829	9.30E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
13	110930364	rs599483	A	G	rs599483	21764829	7.58E-06	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
14	51387590	rs946617	T	G	rs946617	21750111	2.18E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	A	PYGL
14	92735945	rs12434996	G	A	rs12434996	21750111	1.55E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
14	99860840	rs11160518	A	G	rs11160518	21764829	8.91E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
15	25031018	rs17114720	T	C	rs17114720	21764829	7.70E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
15	27557532	rs7497939	G	T	rs7497939	24162738	4.98E-07	GWAS stage only	2.08	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7497939-C	Research Support, Non-U.S. Gov't	G	GABRG3
15	90845500	rs11638027	G	T	rs11638027	24162738	5.47E-12	GWAS stage only	2.56	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs11638027-C	Research Support, Non-U.S. Gov't	G	NA
16	6919183	rs7187960	G	T	rs7187960	24162738	5.56E-07	GWAS stage only	2.17	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7187960-A	Research Support, Non-U.S. Gov't	T	RBFOX1
16	9862556	rs11866328	G	T	rs11866328	22004137	2.00E-08	NA	1.68	[1.40-2.02]	1944 Chinese ancestry cases; 854 Chinese ancestry controls	Chinese(2798)	ALL(2798)	ASN(2798)	ALL(2798)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs11866328-G	Research Support, Non-U.S. Gov't	G	GRIN2A
16	58886531	rs9932019	G	A	rs9932019	21750111	4.08E-05	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	NA
16	84411856	rs958577	C	T	rs958577	21764829	5.13E-06	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
16	84422815	rs11863271	C	T	rs11863271	21764829	2.47E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
17	4836381	rs6065	C	T	rs6065	21750111	2.13E-12	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	GP1BA
17	18064195	rs712274	T	C	rs712274	23321320	8.77E-06	NA	NA	NA	682 Japanese ancestry cases; 1,045 Japanese ancestry controls	Japanese(1727)	ALL(1727)	ASN(1727)	ALL(1727)	Hepatitis C induced liver cirrhosis	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	D006526	Hepatitis C	EFOID:0005129	hepatitis C induced liver cirrhosis	Hepatitis C	NA	Research Support, Non-U.S. Gov't	C	MYO15A
17	65410934	rs7224000	A	G	rs7224000	24503447	3.00E-06	NA	0.12	[NA] unit increase	176 European ancestry individuals	European(176)	ALL(176)	EUR(176)	ALL(176)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	NA	NA	NA	NA	Hepatitis C	NA	Research Support, Non-U.S. Gov't	A	PITPNC1
18	3825114	rs11873667	C	T	rs11873667	21750111	7.08E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	DLGAP1
18	3830245	rs7232492	C	T	rs7232492	21750111	5.36E-06	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	DLGAP1
19	44977071	rs1897824	C	T	rs1897824	24162738	9.42E-08	GWAS stage only	2.08	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs1897824-G	Research Support, Non-U.S. Gov't	A	NA
20	45834279	rs7262634	T	C	rs7262634	24503447	1.00E-06	NA	25	NA	176 European ancestry individuals	European(176)	ALL(176)	EUR(176)	ALL(176)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	HPOID:0012115	Hepatitis	DOID:1883	hepatitis C	NA	NA	NA	NA	Hepatitis C	NA	Research Support, Non-U.S. Gov't	T	NA
21	39803662	rs2836389	T	C	rs2836389	21750111	5.50E-07	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	ERG
21	40280522	rs2000639	A	C	rs2000639	21764829	2.70E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	19580185	rs756656	A	C	rs756656	21764829	4.57E-05	NA	NA	NA	1,683 Indonesian ancestry individuals	Indonesian(1683)	ALL(1683)	ASN(1683)	ALL(1683)	Hepatitis B vaccine response	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D019694	Hepatitis B, Chronic	EFOID:0004645	response to vaccine	Hepatitis B	NA	Clinical Trial	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	21917450	rs131656	G	A	rs131656	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs131656-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21917626	rs131658	C	G	rs131658	24162738	4.46E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs131658-C	Research Support, Non-U.S. Gov't	NA	UBE2L3
22	21919671	rs140488	A	G	rs140488	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140488-A	Research Support, Non-U.S. Gov't	T,C	UBE2L3
22	21919671	rs201008924	A	ACCG	rs140488	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140488-A	Research Support, Non-U.S. Gov't	T,C	UBE2L3
22	21920403	rs131664	G	A	rs131664	24162738	2.06E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs131664-G	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21920817	rs59391722	G	C	rs59391722	24162738	8.75E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs59391722-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21920903	rs131665	A	G	rs131665	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs131665-A	Research Support, Non-U.S. Gov't	T,C	UBE2L3
22	21921294	rs140489	G	A	rs140489	24162738	2.67E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140489-G	Research Support, Non-U.S. Gov't	T,C	UBE2L3
22	21921686	rs140490	G	T	rs140490	24162738	2.33E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140490-G	Research Support, Non-U.S. Gov't	C,A	UBE2L3
22	21922364	rs140491	T	C	rs140491	24162738	2.12E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140491-T	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21922456	rs11089620	C	G	rs11089620	24162738	7.80E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs11089620-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21922904	rs2266959	G	T	rs2266959	24162738	7.80E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2266959-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21923144	rs140492	A	C	rs140492	24162738	2.33E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140492-A	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21925017	rs2256609	A	G	rs2256609	24162738	8.75E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2256609-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21927064	rs140498	G	A	rs140498	24162738	2.07E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140498-G	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21927231	rs140499	C	T	rs140499	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs140499-C	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21928597	rs2266961	C	G	rs2266961	24162738	8.98E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2266961-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21928641	rs181359	G	A	rs181359	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs181359-G	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21928916	rs181360	T	G	rs181360	24162738	3.07E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs181360-T	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21930093	rs73166619	C	T	rs73166619	24162738	8.98E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs73166619-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21930777	rs5754166	C	T	rs5754166	24162738	8.02E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754166-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21932068	rs181362	C	T	rs181362	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs181362-C	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21932264	rs181363	A	G	rs181363	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs181363-A	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21933780	rs181366	C	T	rs181366	24162738	2.07E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs181366-C	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21936152	rs66534072	C	G	rs66534072	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs66534072-C	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21936835	rs374387	C	A	rs374387	24162738	5.11E-06	GWAS stage only,Imputed	1.38	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs374387-C	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21938224	rs5749485	A	C	rs5749485	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5749485-A	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21938590	rs5998576	C	T	rs5998576	24162738	3.08E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5998576-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21938863	rs73166622	G	C	rs73166622	24162738	2.78E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs73166622-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21939675	rs5754217	G	T	rs5754217	24162738	2.38E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754217-G	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21939687	rs5749493	C	A	rs5749493	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5749493-C	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21940189	rs4820091	T	G	rs4820091	24162738	2.46E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4820091-T	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21940310	rs5749495	A	G	rs5749495	24162738	1.03E-06	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5749495-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21941915	rs12484550	C	T	rs12484550	24162738	4.30E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs12484550-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21941981	rs5998599	A	G	rs5998599	24162738	3.02E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5998599-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21942007	rs9621715	G	A	rs9621715	24162738	4.30E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9621715-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21942978	rs5754234	A	T	rs5754234	24162738	4.30E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754234-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21943938	rs1034329	T	C	rs1034329	24162738	2.50E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs1034329-T	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21944478	rs2283789	T	G	rs2283789	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2283789-T	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21945096	rs5749502	T	A	rs5749502	24162738	4.30E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5749502-T	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21945851	rs5998619	G	A	rs5998619	24162738	2.51E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5998619-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21945978	rs73166630	G	A,T	rs73166630	24162738	4.35E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs73166630-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21946173	rs73166632	A	G	rs73166632	24162738	2.64E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs73166632-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21947467	rs2266963	C	G	rs2266963	24162738	3.88E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2266963-C	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21949411	rs2070512	A	C	rs2070512	24162738	2.49E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2070512-A	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21950405	rs4821104	A	G	rs4821104	24162738	5.70E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821104-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21951558	rs417986	C	T	rs417986	24162738	9.06E-06	GWAS stage only,Imputed	1.37	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs417986-C	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21951740	rs5754295	C	A	rs5754295	24162738	2.36E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754295-C	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21953276	rs5994638	A	G	rs5994638	24162738	2.08E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5994638-A	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21953288	rs5998644	T	C	rs5998644	24162738	2.08E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5998644-T	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21956653	rs2283790	A	G	rs2283790	24162738	2.79E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2283790-A	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21957992	rs5754323	T	C	rs5754323	24162738	2.19E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754323-T	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21958304	rs2266964	A	G	rs2266964	24162738	2.57E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2266964-A	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21958872	rs11089629	T	G	rs11089629	24162738	2.41E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs11089629-T	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21959038	rs4821108	G	C	rs4821108	24162738	2.53E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821108-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21963786	rs5754344	A	G	rs5754344	24162738	7.49E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754344-A	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21964761	rs4821112	G	A	rs4821112	24162738	1.46E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821112-G	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21964951	rs5754352	C	T	rs5754352	24162738	1.46E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754352-C	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21966442	rs5998672	G	A	rs5998672	24162738	4.48E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5998672-G	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21968221	rs738127	G	A	rs738127	24162738	1.47E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs738127-G	Research Support, Non-U.S. Gov't	A	UBE2L3
22	21970810	rs4821114	G	C	rs4821114	24162738	7.24E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821114-G	Research Support, Non-U.S. Gov't	G	UBE2L3
22	21971632	rs8139079	T	G	rs8139079	24162738	1.47E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs8139079-T	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21972401	rs2876971	T	G	rs2876971	24162738	1.28E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2876971-T	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21973319	rs4821116	C	T	rs4821116	24162738	2.00E-12	NA	1.22	[1.15-1.30]	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821116-G	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21976934	rs7444	T	C	rs7444	24162738	2.61E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7444-T	Research Support, Non-U.S. Gov't	C	UBE2L3
22	21977047	rs7445	C	A,G,T	rs7445	24162738	1.43E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs7445-C	Research Support, Non-U.S. Gov't	T	UBE2L3
22	21979096	rs11089637	T	C	rs11089637	24162738	1.39E-06	GWAS stage only,Genotyped	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs11089637-T	Research Support, Non-U.S. Gov't	C	NA
22	21979289	rs4821124	T	C	rs4821124	24162738	4.77E-07	GWAS stage only,Imputed	1.45	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821124-T	Research Support, Non-U.S. Gov't	T	NA
22	21979584	rs12158299	C	T	rs12158299	24162738	2.06E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs12158299-C	Research Support, Non-U.S. Gov't	T	NA
22	21979938	rs9619386	C	A,T	rs9619386	24162738	2.47E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs9619386-C	Research Support, Non-U.S. Gov't	C	NA
22	21980257	rs5754422	A	G	rs5754422	24162738	1.91E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754422-A	Research Support, Non-U.S. Gov't	A	NA
22	21980638	rs5754426	T	C	rs5754426	24162738	1.92E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs5754426-T	Research Support, Non-U.S. Gov't	T	NA
22	21980894	rs4821130	C	T	rs4821130	24162738	1.92E-06	GWAS stage only,Imputed	1.41	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs4821130-C	Research Support, Non-U.S. Gov't	C	NA
22	21982249	rs878825	T	C	rs878825	24162738	2.25E-06	GWAS stage only,Genotyped	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs878825-T	Research Support, Non-U.S. Gov't	G	NA
22	21982892	rs2298428	C	T	rs2298428	24162738	6.82E-07	GWAS stage only,Imputed	1.43	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2298428-C	Research Support, Non-U.S. Gov't	C	YDJC
22	21983260	rs2298429	A	G	rs2298429	24162738	4.16E-06	GWAS stage only,Imputed	1.39	NA	951 Han Chinese HBV carrier cases; 937 Han Chinese HBV cleared controls	Han Chinese(1888)	ALL(1888)	ASN(1888)	ALL(1888)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	rs2298429-A	Research Support, Non-U.S. Gov't	G,A	YDJC
22	24996630	rs5751902	C	T	rs5751902	21750111	8.06E-20	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	C	GGT1
22	37928186	rs6000782	A	C	rs6000782	24768677	3.00E-06	NA	1.7	[1.40-2.10]	649 European ancestry cases; 13,436 European ancestry controls	European(14085)	ALL(14085)	EUR(14085)	ALL(14085)	Autoimmune hepatitis type-1	HPOID:0012115	Hepatitis	DOID:2048	autoimmune hepatitis	NA	NA	NA	NA	NA	NA	Multicenter Study	Research Support, Non-U.S. Gov't	C
22	44324727	rs738409	C	G	rs738409	21750111	5.90E-10	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	G	PNPLA3
22	44333694	rs2896019	T	G	rs2896019	21750111	1.98E-12	NA	NA	NA	458 Japanese ancestry cases; 2,056 Japanese ancestry controls	Japanese(2514)	ALL(2514)	ASN(2514)	ALL(2514)	Hepatitis B	HPOID:0012115	Hepatitis	DOID:2043	hepatitis B	D006509	Hepatitis B	EFOID:0004197	hepatitis B infection	Hepatitis B	NA	Research Support, Non-U.S. Gov't	T	PNPLA3

Mapped by lexical matching(Total Items:0)
(Waiting for update.)

Mapped by homologous gene(Total Items:0)
(Waiting for update.)

Chemical(Total Drugs:64)
CUI	ChemicalName	ChemicalID	CasRN	DiseaseName	DiseaseID	DirectEvidence	PubMedIDs
C0019158	acetaminophen	D000082	103-90-2	hepatitis	MESH:D006505	marker/mechanism	2969590
C0019158	acetylcysteine	D000111	616-91-1	hepatitis	MESH:D006505	therapeutic	8104747
C0019158	aminosalicylic acid	D010131	65-49-6	hepatitis	MESH:D006505	marker/mechanism	4131429
C0019158	amitriptyline	D000639	50-48-6	hepatitis	MESH:D006505	marker/mechanism	12638679
C0019158	ampicillin	D000667	69-53-4	hepatitis	MESH:D006505	marker/mechanism	8053440
C0019158	atovaquone	D053626	94015-53-9	hepatitis	MESH:D006505	marker/mechanism	16256055
C0019158	azithromycin	D017963	83905-01-5	hepatitis	MESH:D006505	marker/mechanism	11247598
C0019158	benazepril	C044946	86541-75-5	hepatitis	MESH:D006505	marker/mechanism	12243603
C0019158	caffeine	D002110	1958/8/2	hepatitis	MESH:D006505	marker/mechanism	11394713
C0019158	carbamazepine	D002220	298-46-4	hepatitis	MESH:D006505	marker/mechanism	11431905
C0019158	carbimazole	D002231	22232-54-8	hepatitis	MESH:D006505	marker/mechanism	8724032
C0019158	chloroquine	D002738	1954/5/7	hepatitis	MESH:D006505	therapeutic	5694600
C0019158	choline	D002794	62-49-7	hepatitis	MESH:D006505	marker/mechanism	20368703
C0019158	cimetidine	D002927	51481-61-9	hepatitis	MESH:D006505	marker/mechanism	8123956
C0019158	clotrimazole	D003022	23593-75-1	hepatitis	MESH:D006505	marker/mechanism	1608283
C0019158	dapsone	D003622	80-08-0	hepatitis	MESH:D006505	marker/mechanism	19583683
C0019158	digoxin	D004077	20830-75-5	hepatitis	MESH:D006505	marker/mechanism	12243603
C0019158	diltiazem	D004110	42399-41-7	hepatitis	MESH:D006505	marker/mechanism	12243603
C0019158	dydrogesterone	D004394	152-62-5	hepatitis	MESH:D006505	marker/mechanism	15264122
C0019158	enflurane	D004737	13838-16-9	hepatitis	MESH:D006505	marker/mechanism	7380208
C0019158	ethambutol	D004977	74-55-5	hepatitis	MESH:D006505	marker/mechanism	4131429
C0019158	ethambutol	D004977	74-55-5	hepatitis	MESH:D006505	therapeutic	3098151
C0019158	floxuridine	D005467	50-91-9	hepatitis	MESH:D006505	marker/mechanism	1825358
C0019158	fluoxetine	D005473	54910-89-3	hepatitis	MESH:D006505	marker/mechanism	10405699
C0019158	flutamide	D005485	13311-84-7	hepatitis	MESH:D006505	marker/mechanism	10386060
C0019158	glimepiride	C057619	-	hepatitis	MESH:D006505	marker/mechanism	15247878
C0019158	goserelin	D017273	65807-02-5	hepatitis	MESH:D006505	marker/mechanism	9267134
C0019158	griseofulvin	D006118	126-07-8	hepatitis	MESH:D006505	marker/mechanism	15446108
C0019158	hydroxyurea	D006918	127-07-1	hepatitis	MESH:D006505	marker/mechanism	10433603
C0019158	imatinib mesylate	D000068877	-	hepatitis	MESH:D006505	marker/mechanism	12750713
C0019158	imipramine	D007099	50-49-7	hepatitis	MESH:D006505	marker/mechanism	2760582
C0019158	indinavir	D019469	150378-17-9	hepatitis	MESH:D006505	marker/mechanism	10452668
C0019158	mefloquine	D015767	53230-10-7	hepatitis	MESH:D006505	marker/mechanism	17335720
C0019158	metformin	D008687	657-24-9	hepatitis	MESH:D006505	marker/mechanism	9626034
C0019158	metoprolol	D008790	37350-58-6	hepatitis	MESH:D006505	marker/mechanism	12243603
C0019158	nevirapine	D019829	129618-40-2	hepatitis	MESH:D006505	marker/mechanism	11494710
C0019158	nortriptyline	D009661	72-69-5	hepatitis	MESH:D006505	marker/mechanism	8848811
C0019158	ofloxacin	D015242	82419-36-1	hepatitis	MESH:D006505	marker/mechanism	1506646
C0019158	olanzapine	C076029	132539-06-1	hepatitis	MESH:D006505	marker/mechanism	11217818
C0019158	omeprazole	D009853	73590-58-6	hepatitis	MESH:D006505	marker/mechanism	16096600
C0019158	pantoprazole	C064276	102625-70-7	hepatitis	MESH:D006505	marker/mechanism	12649798
C0019158	phenytoin	D010672	57-41-0	hepatitis	MESH:D006505	marker/mechanism	1147459
C0019158	propylthiouracil	D011441	51-52-5	hepatitis	MESH:D006505	marker/mechanism	11144016
C0019158	pyrazinamide	D011718	98-96-4	hepatitis	MESH:D006505	marker/mechanism	15773037
C0019158	quinine	D011803	130-95-0	hepatitis	MESH:D006505	marker/mechanism	2108777
C0019158	rifampin	D012293	13292-46-1	hepatitis	MESH:D006505	marker/mechanism	10778640
C0019158	rifampin	D012293	13292-46-1	hepatitis	MESH:D006505	therapeutic	3098151
C0019158	riluzole	D019782	1744-22-5	hepatitis	MESH:D006505	marker/mechanism	10190739
C0019158	ritonavir	D019438	-	hepatitis	MESH:D006505	marker/mechanism	10452668
C0019158	rosiglitazone	C089730	-	hepatitis	MESH:D006505	marker/mechanism	11960075
C0019158	sorafenib	C471405	-	hepatitis	MESH:D006505	marker/mechanism	18796127
C0019158	spironolactone	D013148	1952/1/7	hepatitis	MESH:D006505	marker/mechanism	11488711
C0019158	sulindac	D013467	38194-50-2	hepatitis	MESH:D006505	marker/mechanism	20013860
C0019158	sulpiride	D013469	15676-16-1	hepatitis	MESH:D006505	marker/mechanism	7582254
C0019158	tenoxicam	C032801	59804-37-4	hepatitis	MESH:D006505	marker/mechanism	7849359
C0019158	terfenadine	D016593	50679-08-8	hepatitis	MESH:D006505	marker/mechanism	8757175
C0019158	thalidomide	D013792	50-35-1	hepatitis	MESH:D006505	marker/mechanism	11279644
C0019158	ticlopidine	D013988	55142-85-3	hepatitis	MESH:D006505	marker/mechanism	10965556
C0019158	troglitazone	C057693	97322-87-7	hepatitis	MESH:D006505	marker/mechanism	10795774
C0019158	valproic acid	D014635	99-66-1	hepatitis	MESH:D006505	marker/mechanism	15229826
C0019158	vancomycin	D014640	1404-90-6	hepatitis	MESH:D006505	marker/mechanism	16114793
C0019158	vinblastine	D014747	865-21-4	hepatitis	MESH:D006505	marker/mechanism	3091246
C0019158	zafirlukast	C062735	107753-78-6	hepatitis	MESH:D006505	marker/mechanism	12189465
C0019158	zidovudine	D015215	30516-87-1	hepatitis	MESH:D006505	marker/mechanism	1556529

FDA approved drug and dosage information(Total Drugs:25)
DiseaseID	Drug_name	active_ingredients	strength	Dosage Form/Route	Marketing Status	TE code	RLD	RS
MESH:D006505	prilosec	omeprazole	20MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE, DELAYED REL PELLETS;ORAL	Discontinued	None	Yes	No
MESH:D006505	prilosec	omeprazole	20MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE, DELAYED REL PELLETS;ORAL	Discontinued	None	Yes	No
MESH:D006505	omeprazole	omeprazole	20MG	TABLET, DELAYED RELEASE;ORAL	Over-the-counter	None	Yes	Yes
MESH:D006505	omeprazole	omeprazole	20MG	TABLET, DELAYED RELEASE;ORAL	Over-the-counter	None	Yes	Yes
MESH:D006505	norvir	ritonavir	80MG/ML	SOLUTION;ORAL	Prescription	None	Yes	Yes
MESH:D006505	norvir	ritonavir	100MG	CAPSULE;ORAL	Discontinued	None	No	No
MESH:D006505	norvir	ritonavir	100MG	CAPSULE;ORAL	Prescription	None	Yes	Yes
MESH:D006505	norvir	ritonavir	100MG	TABLET;ORAL	Prescription	AB	Yes	Yes
MESH:D006505	amaryl	glimepiride	1MG	TABLET;ORAL	Prescription	AB	Yes	Yes
MESH:D006505	gleevec	imatinib mesylate	EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE;ORAL	Discontinued	None	Yes	No
MESH:D006505	gleevec	imatinib mesylate	EQ 100MG BASE	TABLET;ORAL	Prescription	AB	Yes	No
MESH:D006505	zyprexa	olanzapine	2.5MG	TABLET;ORAL	Prescription	AB	Yes	No
MESH:D006505	zyprexa	olanzapine	10MG/VIAL	INJECTABLE;INTRAMUSCULAR	Prescription	AP	Yes	Yes
MESH:D006505	zyprexa	olanzapine	2.5MG	TABLET;ORAL	Prescription	AB	Yes	No
MESH:D006505	zyprexa	olanzapine	10MG/VIAL	INJECTABLE;INTRAMUSCULAR	Prescription	AP	Yes	Yes
MESH:D006505	retrovir	zidovudine	100MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes
MESH:D006505	retrovir	zidovudine	50MG/5ML	SYRUP;ORAL	Prescription	AA	Yes	Yes
MESH:D006505	retrovir	zidovudine	10MG/ML	INJECTABLE;INJECTION	Prescription	AP	Yes	Yes
MESH:D006505	retrovir	zidovudine	200MG	TABLET;ORAL	Discontinued	None	No	No
MESH:D006505	zidovudine	zidovudine	60MG	TABLET;ORAL	Discontinued	None	No	No
MESH:D006505	zidovudine	zidovudine	60MG	TABLET;ORAL	Discontinued	None	No	No
MESH:D006505	ofirmev	acetaminophen	1GM/100ML (10MG/ML)	SOLUTION;IV (INFUSION)	Prescription	AP	Yes	Yes
MESH:D006505	ofirmev	acetaminophen	1GM/100ML (10MG/ML)	SOLUTION;IV (INFUSION)	Prescription	AP	Yes	Yes
MESH:D006505	acetaminophen	acetaminophen	650MG	SUPPOSITORY;RECTAL	Over-the-counter	None	Yes	Yes
MESH:D006505	acetaminophen	acetaminophen	650MG	SUPPOSITORY;RECTAL	Over-the-counter	None	Yes	Yes

FDA labeling changes(Total Drugs:25)
DiseaseID	Pediatric_Labeling_Date	Trade_Name	Generic_Name_or_Proper_Name	Indications Studied	Label Changes Summary	Product Labeling	BPCA(B)	PREA(P)	BPCA(B) and PREA(P)	Pediatric Rule (R)	Sponsor	Pediatric Exclusivity Granted Date	NNPS
MESH:D006505	12/7/2002	prilosec	omeprazole	Gastroesophageal reflux and erosive esophagitis	Safety and effectiveness established in pediatric patients 2-16 years of age Information on dose, PK parameters, exposure/response and AE profile	Labeling	B	-	-	-	AstraZeneca	-	FALSE'
MESH:D006505	03/20/2008	prilosec	omeprazole	Maintenance healing of erosive esophagitis	Efficacy was extrapolated from adults and older children to 1 to 2 year olds and supported with an open-label trial Unique adverse reactions in pediatric patients included increased respiratory system adverse events and fever. Safety and effectiveness in children less than 1 year of age have not been established Dosing and administration information provided for patients 1 year and older weighing at least 5 kg. New dosage form	Labeling	-	-	B, P	-	AstraZeneca	1/5/2001	FALSE'
MESH:D006505	12/7/2002	prilosec	omeprazole	Gastroesophageal reflux and erosive esophagitis	Safety and effectiveness established in pediatric patients 2-16 years of age Information on dose, PK parameters, exposure/response and AE profile	Labeling	B	-	-	-	AstraZeneca	-	FALSE'
MESH:D006505	03/20/2008	prilosec	omeprazole	Maintenance healing of erosive esophagitis	Efficacy was extrapolated from adults and older children to 1 to 2 year olds and supported with an open-label trial Unique adverse reactions in pediatric patients included increased respiratory system adverse events and fever. Safety and effectiveness in children less than 1 year of age have not been established Dosing and administration information provided for patients 1 year and older weighing at least 5 kg. New dosage form	Labeling	-	-	B, P	-	AstraZeneca	1/5/2001	FALSE'
MESH:D006505	6/10/2005	norvir	ritonavir	Treatment of HIV-infection in combination with other antiretroviral agents	Extended age range from 2 years down to 1 month AE profile in the pediatric population was similar to that for adults Information on dose and PK parameters	Labeling	B	-	-	-	Abbott	06/14/2005	FALSE'
MESH:D006505	6/10/2005	norvir	ritonavir	Treatment of HIV-infection in combination with other antiretroviral agents	Extended age range from 2 years down to 1 month AE profile in the pediatric population was similar to that for adults Information on dose and PK parameters	Labeling	B	-	-	-	Abbott	06/14/2005	FALSE'
MESH:D006505	6/10/2005	norvir	ritonavir	Treatment of HIV-infection in combination with other antiretroviral agents	Extended age range from 2 years down to 1 month AE profile in the pediatric population was similar to that for adults Information on dose and PK parameters	Labeling	B	-	-	-	Abbott	06/14/2005	FALSE'
MESH:D006505	6/10/2005	norvir	ritonavir	Treatment of HIV-infection in combination with other antiretroviral agents	Extended age range from 2 years down to 1 month AE profile in the pediatric population was similar to that for adults Information on dose and PK parameters	Labeling	B	-	-	-	Abbott	06/14/2005	FALSE'
MESH:D006505	11/28/2005	amaryl	glimepiride	Type-2 Diabetes Mellitus	Data are insufficient to recommend pediatric use of glimepiride In an active-controlled, single-blind, 24-week trial, 272 pediatric patients aged 8 to 17 years with Type 2 diabetes were randomized to treatment with glimepiride or metformin. Trial suggested differences favoring metformin AE profile in the pediatric population was similar to that for adults Information on PK parameters	Labeling	-	-	B, P	-	Aventis	9/6/2005	FALSE'
MESH:D006505	09/27/2006	gleevec	imatinib mesylate	Treatment of newly diagnosed pediatric patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase	Extended age range for the treatment of newly diagnosed CML down to pediatric patients There are no data in children < 2 years of age Follow-up in children with newly diagnosed Ph+ chronic phase CML is limited Information on hematologic toxicities, AE profile, clinical studies and dosing guidelines new for newly diagnosed pediatric patients	Labeling	-	-	B, P	-	Novartis	9/6/2006	FALSE'
MESH:D006505	09/27/2006	gleevec	imatinib mesylate	Treatment of newly diagnosed pediatric patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase	Extended age range for the treatment of newly diagnosed CML down to pediatric patients There are no data in children < 2 years of age Follow-up in children with newly diagnosed Ph+ chronic phase CML is limited Information on hematologic toxicities, AE profile, clinical studies and dosing guidelines new for newly diagnosed pediatric patients	Labeling	-	-	B, P	-	Novartis	9/6/2006	FALSE'
MESH:D006505	08/14/2008	zyprexa	olanzapine	schizophrenia; bipolar disorder	Safety and effectiveness have not been established for patients less than 18 years of age In an analysis of placebo-controlled olanzapine monotherapy studies of adolescent patients, including those with schizophrenia or bipolar disorder, olanzapine was associated with: oHyperglycemia - a statistically significantly greater mean change in fasting glucose levels compared to placebo oHyperlipidemia statistically significant increases compared to placebo in fasting triglycerides, fasting total cholesterol and fasting LDL cholesterol oWeight gain olanzapine treated patients gained an average of 4.6 kg, compared to an average of 0.3 kg in placebo-treated patients with a median exposure of 3 weeks; Average weight gain during long-term therapy was 7.4 kg	-	B	-	-	-	Lilly	10/1/2007	FALSE'
MESH:D006505	08/14/2008	zyprexa	olanzapine	schizophrenia; bipolar disorder	Safety and effectiveness have not been established for patients less than 18 years of age In an analysis of placebo-controlled olanzapine monotherapy studies of adolescent patients, including those with schizophrenia or bipolar disorder, olanzapine was associated with: oHyperglycemia - a statistically significantly greater mean change in fasting glucose levels compared to placebo oHyperlipidemia statistically significant increases compared to placebo in fasting triglycerides, fasting total cholesterol and fasting LDL cholesterol oWeight gain olanzapine treated patients gained an average of 4.6 kg, compared to an average of 0.3 kg in placebo-treated patients with a median exposure of 3 weeks; Average weight gain during long-term therapy was 7.4 kg	-	B	-	-	-	Lilly	10/1/2007	FALSE'
MESH:D006505	4/12/2009	zyprexa	olanzapine	Treatment of manic or mixed episodes of bipolar I disorder and schizophrenia in adolescents ages 13-17	Extended schizophrenia and manic or mixed episodes of bipolar I disorder indications from adults to adolescents 1317 years of age Safety and effectiveness in children < 13 years of age have not been established Recommended starting dose for adolescents is lower than that for adults Compared to patients from adult clinical trials, adolescents were likely to gain more weight, experience increased sedation, and have greater increases in total cholesterol, triglycerides, LDL cholesterol, prolactin and hepatic transaminase levels Information on dosing, adverse reactions, pharmacokinetics, clinical studies	Labeling	B	-	-	-	Lilly	10/1/2007	TRUE'
MESH:D006505	4/12/2009	zyprexa	olanzapine	Treatment of manic or mixed episodes of bipolar I disorder and schizophrenia in adolescents ages 13-17	Extended schizophrenia and manic or mixed episodes of bipolar I disorder indications from adults to adolescents 1317 years of age Safety and effectiveness in children < 13 years of age have not been established Recommended starting dose for adolescents is lower than that for adults Compared to patients from adult clinical trials, adolescents were likely to gain more weight, experience increased sedation, and have greater increases in total cholesterol, triglycerides, LDL cholesterol, prolactin and hepatic transaminase levels Information on dosing, adverse reactions, pharmacokinetics, clinical studies	Labeling	B	-	-	-	Lilly	10/1/2007	TRUE'
MESH:D006505	6/11/2009	retrovir	zidovudine	Treatment of HIV-1 infection in combination with other antiretroviral agents	Provided dosing recommendations for patients 4 weeks to < 6 weeks of age and weighing 4 kg to < 9 kg	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	6/11/2009	retrovir	zidovudine	Treatment of HIV-1 infection in combination with other antiretroviral agents	Provided dosing recommendations for patients 4 weeks to < 6 weeks of age and weighing 4 kg to < 9 kg	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	6/11/2009	retrovir	zidovudine	Treatment of HIV-1 infection in combination with other antiretroviral agents	Provided dosing recommendations for patients 4 weeks to < 6 weeks of age and weighing 4 kg to < 9 kg	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	6/11/2009	retrovir	zidovudine	Treatment of HIV-1 infection in combination with other antiretroviral agents	Provided dosing recommendations for patients 4 weeks to < 6 weeks of age and weighing 4 kg to < 9 kg	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	09/19/2008	retrovir syrup, capsules and tablets	zidovudine	Used in combination with 18 other antiretroviral agents for the treatment of HIV-1 infection	Dosing and administration information provided to children 6 weeks to less than 18 years of age Macrocytosis was reported in the majority of pediatric patients receiving Retrovir 180 mg/m2 every 6 hours in open-label studies New dosing regimen	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	6/11/2009	retrovir	zidovudine	Treatment of HIV-1 infection in combination with other antiretroviral agents	Provided dosing recommendations for patients 4 weeks to < 6 weeks of age and weighing 4 kg to < 9 kg	Labeling	-	P	-	-	GlaxoSmithKline	-	TRUE'
MESH:D006505	2/11/2010	ofirmev	acetaminophen	Management of mild-to-moderate pain, for the management of moderate-to-severe pain with adjunctive opioid analgesics, and for the reduction of fever	The safety and effectiveness of Ofirmev for the treatment of acute pain and fever in pediatric patients ages 2 years and older is supported by evidence from adequate and well-controlled studies of Ofirmev in adults. Additional safety and PK data was collected in 355 from premature neonates to adolescents. The effectiveness of Ofirmev for the treatment of acute pain and fever has not been studied in pediatric patients < 2 years of age.The PK exposure of Ofirmev observed in children and adolescents is similar to adults, but higher in neonates and infants. Dosing simulations from PK data in infants and neonates suggest that dose reductions of 33% in infants 1 month to < 2 years of age, and 50% in neonates up to 28 days, with a minimum dosing interval of 6 hours, will produce a PK exposure similar to that observed in children age 2 years and olderMost common adverse reactions in pediatric patients were nausea, vomiting, constipation, pruritus, agitation, and atelectasis.Information on dosing, clinical studies, adverse reactions and PK parametersNew dosage form and route of administration	Labeling	-	P	-	-	Cadence	-	FALSE'
MESH:D006505	01/27/2017	ofirmev	acetaminophen	Treatmeny of pain and fever in pediatric patients birth to 2 years	Treatment of pain Efficacy was not demonstrated in pediatric patients younger than 2 years in a double-blind, placebo-controlled study of 198 pediatric patients younger than 2 years. Pediatric patients less than 2 years of age, including neonates from 28 to 40 weeks gestational age at birth, were randomized to receive opioid plus acetaminophen or opioid plus placebo. No difference in analgesic effect of intravenous acetaminophen, measured by assessment of reduced need for additional opioid treatment for pain control, was observed. Treatment of fever The safety and effectiveness for the treatment of fever in pediatric patients, including premature neonates born at 32 weeks or greater gestation is supported by adequate and well-controlled studies of Ofirmev in adults, clinical studies in 244 pediatric patients 2 years and older, and safety and pharmacokinetic data from 239 patients younger than 2 years including neonates 32 weeks or greater gestational age. Information on dosing, clinical trials. Postmarketing study.	Labeling	-	-	B,P	-	Mallinckrodt	11/7/2016	FALSE
MESH:D006505	2/11/2010	ofirmev	acetaminophen	Management of mild-to-moderate pain, for the management of moderate-to-severe pain with adjunctive opioid analgesics, and for the reduction of fever	The safety and effectiveness of Ofirmev for the treatment of acute pain and fever in pediatric patients ages 2 years and older is supported by evidence from adequate and well-controlled studies of Ofirmev in adults. Additional safety and PK data was collected in 355 from premature neonates to adolescents. The effectiveness of Ofirmev for the treatment of acute pain and fever has not been studied in pediatric patients < 2 years of age.The PK exposure of Ofirmev observed in children and adolescents is similar to adults, but higher in neonates and infants. Dosing simulations from PK data in infants and neonates suggest that dose reductions of 33% in infants 1 month to < 2 years of age, and 50% in neonates up to 28 days, with a minimum dosing interval of 6 hours, will produce a PK exposure similar to that observed in children age 2 years and olderMost common adverse reactions in pediatric patients were nausea, vomiting, constipation, pruritus, agitation, and atelectasis.Information on dosing, clinical studies, adverse reactions and PK parametersNew dosage form and route of administration	Labeling	-	P	-	-	Cadence	-	FALSE'
MESH:D006505	01/27/2017	ofirmev	acetaminophen	Treatmeny of pain and fever in pediatric patients birth to 2 years	Treatment of pain Efficacy was not demonstrated in pediatric patients younger than 2 years in a double-blind, placebo-controlled study of 198 pediatric patients younger than 2 years. Pediatric patients less than 2 years of age, including neonates from 28 to 40 weeks gestational age at birth, were randomized to receive opioid plus acetaminophen or opioid plus placebo. No difference in analgesic effect of intravenous acetaminophen, measured by assessment of reduced need for additional opioid treatment for pain control, was observed. Treatment of fever The safety and effectiveness for the treatment of fever in pediatric patients, including premature neonates born at 32 weeks or greater gestation is supported by adequate and well-controlled studies of Ofirmev in adults, clinical studies in 244 pediatric patients 2 years and older, and safety and pharmacokinetic data from 239 patients younger than 2 years including neonates 32 weeks or greater gestational age. Information on dosing, clinical trials. Postmarketing study.	Labeling	-	-	B,P	-	Mallinckrodt	11/7/2016	FALSE